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Abstract 
 
 
One of the major research aims in Materials Science and Engineering for the past 
two decades has pertained to the development of capabilities to manipulate and 
characterize materials on the molecular and atomic level. This capability has been largely 
driven by technological and engineering advances in the semiconducting industry, where 
better controls and higher resolution equates to better device performance and higher 
profits. Inspired by such lithographic approaches, there has been a parallel push to drive 
bottom up, self-assembly techniques, where short and long range forces drive the 
assembly of nanoscale components assemble into hundreds of billions of complexes and 
devices simultaneously. Correspondingly, our ability to form high quality and 
increasingly complex structures based on the principles of self-assembly demands the 
development of a highly repeatable, robust, and well characterized system. While the 
concepts of self-assembly is simple, the realization of high quality nanoscale assembly 
remains a stubbornly difficult challenge due a fundamental trade-off between degree of 
control, throughput (yield) of the assembly, and complexity of the final assembly. 
In the early 1980’s, Professor Nadrian Seeman published his seminal work on the 
design of DNA tiles, which along with his group, became the field now known as 
structural DNA nanotechnology. Professor Chad Mirkin and several others then later 
realized the power of complementary DNA can be utilized as a “smart glue” to 
programmably assembly many different types of nanomaterials. In the following three 
decades, DNA based nanotechnology has advanced greatly due to the commercial 
availability of artificially synthesized oligonucleotides, a vast library of chemical and 
enzymatic modifications, and the work of hundreds of groups around the world. This 
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thesis will describe efforts made to advance the field by identifying new conjugation 
chemistries that enable two and three dimensional scaffolding of nanomaterials on 
complex DNA structures.  
Another extraordinary property of DNA was first described by Larry Gold and 
Jack Szostak and has since evolved into what is now functional DNA (f-DNA). The role 
of proteins (peptide chains) and ribozymes (RNA molecules) in a litany of biological 
enzymatic functions have long been studied. Functional DNA follows the hypothesis that 
certain DNA sequences will exhibit catalytic activity (much like ribozymes and proteins) 
or target recognition (much like antibodies). Of particular interest to the current thesis is 
functional DNA that has targeting properties based on their three dimensional structure in 
solution, also common known as DNA aptamers. Aptamers are selected through a 
process known as Systematic Evolution of Ligands by Exponential Enrichment or 
SELEX. DNA aptamers have drawn a great deal of attention as the next generation 
antibody due to (1) lower development and production cost, (2) higher stability, (3) more 
simple to characterize and modify. With a growing library of aptamers with target 
specific interactions, some of the most exiting research is the development of next 
generation medical imaging and therapies based on aptamer functionalities, in 
combination with novel nanomaterials. In this thesis, we describe work introducing a new 
type of optically active nanoparticles, that exhibits useful properties for disease diagnosis 
and therapy while reducing unwanted side effects. 
As the rest of the thesis will demonstrate in great detail, the future of DNA based 
nanotechnologies is tremendous, with the potential to impact electronics, optics, and 
medical devices of the future.   
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CHAPTER 1 
INTRODUCTION 
Portions of this chapter were published as “DNA aptamer functionalized nanomaterials 
for intracellular analysis, cancer cell imaging, and drug delivery” Hang Xing, Ngo Yin 
Wong, Yu Xiang, and Yi Lu, Current Opinion in Chemical Biology 2012, 16, 429-435 
1.1 Functional Nanomaterials and Their Emerging Applications 
A material or object is considered “nanoscale” when one or more of the 
dimensions are between 1 and 100 nanometers. While absolute size definitions can be at 
times, arbitrary, the common theme uniting nanoscale materials and more specifically, 
functional nanomaterials is the emergence of unique size dependent properties that is not 
apparent when the material is treated as a bulk material. Interestingly, the properties of 
nanoscale materials has been explored since the 1800’s when stained glass were infused 
with different sizes of colloidal gold to infuse a gold or red color. While these ancient 
explorations lacked the theory and technology to fully understand the properties of gold 
colloids, their work became the inspiration for generations of scientists since to develop 
and understand functional nanoscale materials for an ever growing list of applications, 
including electronics and photonics, to energy and catalysis, and the next generation of 
medical therapies that promises to be more effective, less invasive, while dramatically 
reducing side effects. 
Over the last two decades, an area of particular interest and tremendous has been 
the development of functional nanomaterials such as metallic nanoparticles(1,2), 
semiconducting nanocrystals (quantum dots) (3-5), carbon nanotubes (6-8), nanorods (9), 
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and nanoshells (10,11), to only name a few.(12) These materials all exhibit unique 
properties (optical, electronic, and catalytic) due to their small size, effects that are often 
not observable at the bulk scale. Subsequently, these material properties have been 
exploited for a wide range of applications such as electronics, optics, energy storage, 
catalysis, sensing, cellular imaging, and biomedical procedures. (13-16) 
Another important concept in nanotechnology is the assembly and patterning of 
nanomaterials such that the aggregate behavior of the assembly is different or exhibit 
enhancements over a single particle or an uncontrolled aggregate. Phenomenon such as 
Förester (Fluorescence) resonant energy transfer (FRET), plasmonic hotspots, and 
surface enhanced Raman spectroscopy (SERS) are all distance dependent mechanisms 
between two or more electronically active materials. FRET and SERS, in particular have 
found wide adoption for detailed, nanoscale characterization of proteins, as well as 
extremely sensitive detection of small molecules and proteins. Our ability to control these 
nanoscale assemblies will be critical to develop a deeper understanding of these 
interactions as well as allow the design and fabrication of functional devices to take 
advantage of these nanoscale effects.  
1.2 Bottom-Up Manufacturing and Structural DNA Nanotechnology 
To date, there are two major schools of thought regarding nanoscale patterning. 
The first is the “top-down” approach. This powerful concept has been and continues to be 
the basis of semiconductor processing techniques, where a bulk material (usually silicon) 
is patterned and etched to reveal ever shrinking nanoscale features. Since the bulk of the 
work is done through optical lithography, many speculated that the features sizes of such 
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nanoscale structures will be limited by the diffraction limit, often estimated by λ/2 where 
λ is the wavelength of the incident light. Many had speculated that this limitation would 
hold these “top-down” techniques to size features of roughly 200 nanometers (nm). 
However, continued advances in technology have allowed silicon processors to continue 
to push the feature size into the tens of nanometers. One major drawback of “top-down” 
fabrication techniques, however, is complexity and cost. As industrial companies 
continue to follow “Moore’s law” into the tens of nanometers, the costs have 
correspondingly escalated dramatically with a modern semiconductor “Fab” now costing 
several billion dollars.  
The other fundamental approach to nanoscale patterning is often referred to as 
“Bottom-Up” techniques. Rather than starting with a bulk material, bottom up techniques 
start with atoms and molecules and through specific interactions, assemble into larger, 
ordered structures. These techniques are often biology inspired, and rely on 
intermolecular forces or a biological template to self-assemble individual components 
into ordered one, two, and three dimensional structures. Bottom up techniques are 
intrinsically lower cost and less complex, but suffers from reproducibility as well as 
maintaining a high level of spatial control over a large area. But rather than competing on 
a “race to the bottom” with top down approaches, bottom up approaches are often 
complementary to top down methods and are often appropriate under a different set of 
scenarios where nanometer spatial control of heterogeneous materials, soft substrates, and 
biocompatibility are of importance. Some of the most commonly explored materials for 
bottom up, self-assembled structures are block-copolymers, peptide/proteins, and DNA. 
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The central dogma of biology states the role of deoxyribonucleic acids (DNA) is 
to make ribonucleic acids (RNA), which in turns, make proteins. However, the properties 
of DNA, when viewed through a materials scientist’s eyes, becomes a biopolymer with 
predictable structure, programmable chemistry, nanometer resolution, good thermal and 
chemical stability, and double strand persistence length of roughly 50 nanometers. 
Professor Nedrian Seeman, in 1982, theorized that DNA, due to its repetitive nature and 
structural stability would be an ideal scaffold to create predictable and crystalline 
structures, which can be in turn, used to study difficult to crystallize proteins. As his 
website states today, “Ultimate goals for this approach include the rational synthesis of 
periodic matter and the assembly of a biochip computer. The reason for trying to 
synthesize periodic matter in a rational fashion is the weakness of the current 
crystallization protocol and the expectation that DNA sticky ends can be used to 
assemble DNA cages containing oriented guests. If we can achieve this goal, we will 
have a good handle on the crystallization of all biological molecules.”  
DNA is capable of forming sequence specific double helixes through base-pairing 
of complementary bases. In his 1982 seminal paper, Professor Seeman introduced the 
concept of what is to become structural DNA nanotechnology, by designing a series of 
branched structural motifs that mimicked naturally occurring DNA structures known as 
“Holliday junctions.” In the subsequent decades, Professor Seeman and a growing cohort 
designed and created increasing robust and complex motifs, such as the double and triple 
crossover motifs that significantly increased the stability of a DNA structure. (17-19) 
Later, he and co-workers designed and generated much more complex DNA structures 
with variations of the double crossover motif, triple crossover motifs, two dimensional 
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lattices, and polyhedral DNA structures such as the cube, six-connected network, 
pentagonal dedecahedron and truncated octahedron. (20,21) Novel motifs are 
continuously being introduced, and recently, a half-crossover based structure was 
reported by Yin et al., which allowed them to form DNA tubes composed of four-helix 
bundles all the way up to twenty-helix bundles. (22) In another work, Hansen et al. 
introduced a way to incorporate some features of both the origami method and the tile 
based self-assembly to produce weave tile structures. (23) They reported formation of 
flexible structures that were used to increase the anticoagulant activity of thrombin-
binding aptamers. The structure was composed of two long strands that have 
complementarities for each other (woven strands) and possess the sticky ends that 
provide complementary sequences for other tiles to produce the lattices. Unlike the other 
tile based or origami methods, the weave tile structure does not form based on the holiday 
junctions or crossovers and just benefits from the exact design of the structure based on 
the geometry of the DNA bases. The new design solves the problem of incorrect strand 
stoichiometry that has been reported with other tile-based assemblies because this 
approach only uses two DNA strands. 
The DNA tile based system has also been used to make 3D structures. The first 
tile based 3D DNA structure was introduced by Seeman. (24) However, the study only 
provided indirect evidence for the formation of the 3D structure. A few years later other 
studies reported the construction of 3D DNA structures. An interesting study by Shih et 
al. reported formation of an octahedron by self-folding of a 1.7 kb single-stranded DNA 
(heavy strand) and a few smaller strands (light strands). (25) This structure might be 
considered as an early example of the DNA origami technique. Another study by 
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Goodman et al. reported construction of a tetrahedron DNA structure. They have also 
reported conformational changes in the structure due to restriction enzyme digestions (26) 
or by strand displacement. (27) Formation of various 3D structures such as triangular, 
cubic, hexameric prisms was reported by Aldaye and Sleiman. (28) Another interesting 
study by He et al. reported the formation of tetrahedron, dodecahedron, buckyball 
structures (27) and a DNA octahedral structure. (29) 
The addition of dynamic properties to DNA nanostructures is another practice 
which has been applied over the last decade. (30-34) One of the most often employed 
strategies to trigger and produce dynamics in DNA nanostructures is strand displacement, 
which is a process of displacing pre-hybridized strands (one or more) in a DNA complex 
(consisting of two or more strands) via partial or full hybridization with a new strand 
(usually called a displacement strand), with a longer region of complementarity. To start 
strand displacement, the displacement strand hybridizes a single-stranded complementary 
region in the DNA complex and by branch migration displaces the pre-hybridized strand. 
The single-stranded region in the initial complex is called a toehold. Toehold based 
strand displacement in DNA nanotechnology was initially proposed by Yurke et al.. (30) 
They demonstrated a nanodevice which switched from open to closed states and vice 
versa by multi step hybridization and strand displacement. Later, scientists have 
programmed the movement of DNA molecules based on toehold strand displacement. 
Shih and Pierce designed a DNA device driven by fuel strands on top of a DNA tube (31), 
among other DNA walker designs. (35-38) Recently, Wang et al. introduced a new 
strategy for stepwise walking of a bipedal walker, where the forward step is triggered by 
introducing Hg2+ and H+ ions while the backward step is triggered by OH- ions and 
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cysteine. (39) Tile-based DNA nanostructure architecture is a promising method, but 
there are major drawbacks for the tile-based assembly strategy. First, the design of 
complex structures using the tile method is a challenge since one needs to design and 
check the new sequence for each step, which is a time consuming and problematic step. 
Secondly it is very hard to control production of complex high order nanostructures, and 
even though some of the structures have finite size and shape, many other structures such 
as arrays or grids grow as long as sticky strands are available, and therefore there is no 
control over size. Finally, in order to obtain the predicted structure the strands need to be 
highly quantitatively controlled. 
The “DNA origami” method was first proposed and implemented by Paul W. K. 
Rothemund in 2006 (40), in which he folded a long viral single-stranded DNA (ssDNA) 
molecule to create DNA structures of arbitrary shapes. However, DNA origami was 
foreshadowed by at least two other prior works. In the first attempt, Yan et al. reported 
formation of the nano arrays by using a long scaffold and some shorter strands. (41) 
However, they could not demonstrate exact control over size and shape of the structures. 
Another advance, mentioned previously, was published by Shih et al. who reported 
formation of an octahedron by self-folding of a long single-stranded DNA and a few 
smaller strands. (25) Moreover, a long time ago Williamson suggested the term “RNA 
origami” for 3D structures that could be formed by self-folding of the RNA molecules. 
(42) 
The term origami refers to the Japanese art of folding paper into a special, often 
complex shape. DNA origami, therefore, is so named since one long strand of DNA is 
folded to produce the desired structure by the help of smaller staple strands. The origami 
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folding process is based on folding of the large ssDNA (usually the 7.3 kilobase genome 
of the M13 bacteriophage) with an excess of smaller complementary strands (typically 32 
bases). These small strands are called “staple” strands and are complementary to at least 
two distinct segments of the long ssDNA. Long ssDNA and an excess of staple strands 
are then heat-annealed in a specific buffer with high concentration of magnesium to form 
the origami. 
The origami method has been applied to construct two dimensional and more 
recently three dimensional DNA nanostructures. In the first demonstration of the 
technique, Rothemund illustrated construction of many arbitrary structures such as stars, 
squares, rectangles, smiley faces, triangles and other complex structures. He also 
demonstrated the addressability of the structures by showing formation of designed 
patterns on the top of the origami tiles. Only a few months after Rothemund’s original 
origami work was published, a Chinese group reported construction of a map of china by 
this method. (43) In 2008 software to design arbitrary structures, called SARSE, was 
released (44), and it was rapidly followed by caDNAno, an improved tool for the design 
of 2D and 3D DNA origami (45). More recently, canDo (46), an online program to 
predict properties, such as flexibility and predicted final shape of designed structures, was 
developed by the Dietz group. 
Very recently Endo et al. reported formation of multi-domain DNA origami by 
using origami four-way junctions (47), and in a very similar work Rajendran et al. 
reported construction of the multi-domain DNA origami. (48) The DNA origami method 
has been highly successful and popular since it does not require any sequence design, 
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time-consuming stoichiometry studies or control over the quality and quantity of the 
staple strands, which are main challenges in tile based DNA architecture. 
DNA origami tiles have gained wide interest since they are effective platforms for 
the spatial dependent study of other systems. In the earliest work, patterns (hairpin 
dumbbells) on top of the origamies were imaged by AFM. (40) Since then, DNA origami 
has been used as a template for patterning using streptavidin molecules (49) and Shen et 
al. showed patterning of enhanced green fluorescent protein on top of the origami. (50) 
DNA origami tiles has also been used to investigate binding of thrombin molecules to 
their aptamers. (51) 
Moreover, patterning of gold nanoparticles has been reported on the six-helix 
bundle DNA origami (52) and rectangular origami. (53) By placing fluorophores at 
specific positions of DNA origami as a ruler, calibration objects for super-resolution 
optical microscopy have been reported. (54) DNA origami nanotubes have been aligned 
between gold islands (55) and recently, Liu et al. reported gold metallization of branched 
DNA origami. (56) 
In an interesting study, Manue et al. (57) showed positioning of single-walled 
carbon nanotubes on top of rectangular origami. They demonstrated stable field-effect 
transistor-like behavior of the structure, which is an important advance toward using a 
complex system of DNA and nanotubes toward applications in nanoelectronics. 
Eskelinen et al. positioned carbon nanotubes on top of the DNA origami by aid of 
interactions between streptavidin molecules and biotinylated DNA strands precisely 
positioned on the origami and wrapped around the carbon nanotube. (58) In another 
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major step toward wafer scale origami applications, DNA origamies have been placed 
and oriented on lithographically patterned surfaces thus combining the top-down and 
bottom-up approaches. (59) Furthermore, Hung et al. reported specific positioning of 
gold nanoparticles on top of lithographically confined DNA origamies. (60) 
In a very interesting development, scientists from Hao Yan’s and Erik Winfree’s 
groups separately demonstrated molecular robots which move along a predefined path on 
top of a rectangular origami. (61) The movement of this walker is based on a simple 
enzymatic reaction. In another advance, Gu and colleagues from Seeman’s group 
introduced a DNA walker molecule which moves on top of an origami in programmed 
path and collects cargos which are placed at specific positions on the origami. (62) In 
another study Wickham et al. programmed directed, uniform and continuous translation 
of a molecular motor along a 100 nm track on flat DNA origami. (63) 
1.3 Introduction to Functional DNA 
Chapter five of this thesis discusses the use of aptamer functionalized DNA 
mediated gold nanoflowers for simple imaging and diagnosis of diseased cells. Here, a 
brief introduction to functional DNA, targeted vs. passive uptake, as well as previous 
successes in aptamer/ gold systems for in vitro and in vivo applications will be discussed 
below. 
As we have highlighted above, DNA is among the most important class of 
biopolymers and is known primarily as a carrier of genetic information. (64,65) Since the 
early 1990s, however, DNA sequences have been identified that perform catalytic 
reactions (called DNAzymes, or deoxyribozymes) (42,66) like protein enzymes, or 
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exhibit target specific binding (aptamers) very much similar to antibodies. (67) 
DNAzymes, aptamers and their combination (called aptazymes or allosteric DNAzymes) 
(68) are now collectively called functional DNA. These functional DNA molecules have 
not been discovered in nature thus far, instead they have been isolated via a combinatorial 
biology technique known as in vitro selection (69), or a process also known as systematic 
evolution of ligands by exponential enrichment (SELEX). (70,71) 
A unique feature of functional DNA and related functional RNA molecules 
(ribozymes and RNA aptamers) is their ability to specifically bind a broad range of 
analytes including inorganic, organic, and biomolecules, as well as bacteria, viruses, and 
cancer cells. (72-74) The binding affinity of these functional DNA/RNA molecules to 
specific targets can rival that of protein antibodies. In addition to their ability to recognize 
the large variety of targets, functional DNAs offer a number of competitive advantages 
over other molecules such as antibodies. (75) First, functional DNAs are isolated by in 
vitro selection and can be chemically synthesized and engineered in a standard chemistry 
lab after their sequences are determined, whereas antibody preparation often requires 
animals or cell cultures. Second, functional DNAs are generally more stable under harsh 
conditions, such as high temperature and non-aqueous solvent that are often encountered 
during materials synthesis and engineering; if the DNA sequences become denatured, 
they are easily refolded to their native active conformation, while denatured antibodies 
usually cannot be recovered. Finally, these functional DNAs induce little or no 
immunogenicity in therapeutic applications compared to those protein antibodies. Despite 
these advantages, there is still a lack of general methods to transform the selective 
binding of these functional DNAs to physically detectable signals such as fluorescence or 
12 
 
colors. Therefore, integration of functional DNA with nanomaterials provides new hybrid 
systems that combine specific molecular recognition or catalytic properties of functional 
DNA with diverse and strong signal transduction of nanomaterials. This novel 
combination has yielded stimuli responsive nanomaterial assemblies and various types of 
sensors for selective and sensitive detection of a wide range of analytes.  (76-80) 
Aptamers, in particular, are short single stranded DNA or RNA sequences that 
have been selected and refined for highly specific binding to a target of interest by in 
vitro selection or systematic evolution of ligands by exponential enrichment (SELEX). 
(70,71,81) In the past two decades, the technology has evolved quickly and has since 
found particular interest in environmental sensing, cancer imaging/diagnosis, and disease 
therapy. (82-89) Due to its automated synthesis, high stability, and well established 
selection process, DNA aptamers have become one of the most promising techniques for 
introducing target specificity to nanomaterials for intracellular imaging, diagnosis, and 
therapy. (80,90) Additionally, aptamers (10-15 kDa) are generally smaller in size 
compared with antibodies (150 kDa) and single chain variable fragments (25 kDa) and 
therefore accumulates more quickly within tumor tissue.  
1.4 Aptamer Functionalized Nanomaterials for Biomedical Applications 
Metal nanoparticles have been used widely for the studies of cellular uptake and 
analysis due to their simple synthesis, easy modifications, and biocompatibility. For 
applications in cellular analysis, gold and silver nanoparticles have been especially 
common owing to their excellent plasmonic properties, which have enabled significant 
advances in localized surface plasmon resonance (LSPR) for applications such as surface 
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enhanced Raman spectroscopy. (91) When in close proximity to the surface of a 
plasmonic metal, the Raman signal can achieve 1014 enhancements, due to 
electromagnetic enhancements from plasmonic “hot spots”. Nanoparticles (92), 
nanoshells (93), nanoflowers (94), nanorods (95), and many other nanostructures (96) 
therefore, have been recently been explored for their plasmonic properties in cell imaging, 
uptake mechanisms, and detection of various analytes. (97) The reader is directed to other 
recent reviews that focus on SERS/plasmonic applications of nanoparticles for cellular 
analysis. (98) 
Other types of nanomaterials such as silica nanoparticles, quantum dots (QDs), 
and carbon based nanomaterials have also been applied in cellular applications. (99-101) 
Nanosized silica is widely known for excellent compatibility and has been used 
extensively in cellular studies. (102) More recently, mesoporous structures dramatically 
increased the surface area of silica nanoparticles and enabled high loading of cargo for 
cellular imaging and delivery. (103) Another material of interests is semiconducting QDs. 
Because of their fluorescence stability, board absorption and narrow emission band, they 
are uniquely suited for high resolution (104) and multiplex imaging of cells. (105) 
Carbon based nanomaterials such as carbon nanotubes, fullerenes, and most recently 
graphene and graphene oxide are also promising nanomaterials for cellular applications, 
including the use of stabilized graphene oxide in cellular imaging and drug delivery. 
(106-108) 
The materials discussed above have all demonstrated good biocompatibility and 
an ability to achieve either some function in diagnostics, therapy, or both. One of the 
remaining challenges in nanomaterial based diagnostics and therapy is the idea of 
14 
 
transitioning from “passive targeting” to “active targeting” mechanisms. In passive 
targeting, nanoparticles tend to accumulate at tumor sites due to the enhanced permeation 
retention effect (EPR). Normal vasculature is impenetrable to molecules larger than 2 – 4 
nanometers (nm), except for major organs such as the kidney, liver, and spleen. In 
contrast, tumor vasculatures tend to be “leaky” due to rapid, uncontrolled growth. As a 
result, tumors exhibit increased permeability to macromolecules and particles up to 600 
nm. The EPR effect has been widely exploited to deliver nanoscale drug formulations to 
tumor sites, with successful clinical examples such as DaunoXome (liposomal 
daunorubicin; Gilead Sciences, Foster City, California, US) and Doxil (PEG-coated 
liposomal doxorubicin; Centocor Ortho Biotech, Ratitan, New Jersey, USA). Passive 
targeting is effective for nano-formulated therapeutics for tumor tissue, however, the 
therapeutic agents must be internalized into the tumor cell to exhibit any effectiveness. 
This uptake can be achieved by active targeting. 
Active targeting takes advantage of specific proteins or other ligands that are over 
expressed specifically on the surface of tumor cells that differentiate diseased cells from 
normal, healthy cells. Therefore, active targeting is achieved by attaching a target 
recognition component to the nanocarrier or nanoparticle. Some of these targeting agents 
include albumin, FA, galactose, peptides (RGD, VEFT peptide), proteins, antibodies, and 
the focus of the below discussion, aptamers.  
While there are many published examples of target specific aptamers, examples of 
aptamers that have found clinical relevance is expectedly far fewer. In particular the A10 
RNA aptamer (a competitive inhibitor of prostate cancer tumor marker) and AS1411 
aptamer (binds specifically to nucleolin protein, a nuclear protein overexpressed in the 
15 
 
cytoplasm and the surface of many cancer cells, such as human breast cancer cells) have 
found wide interest by researchers interested in targeted uptake of nanoparticles. 
Researchers have also addressed the specificity issues of targeting a single biomarker by 
conjugating several targeting ligands to enhance targeting specificity and signal 
sensitivity. Ko et al. (109) reported a multimodal nanoparticle that consisted of the 
AS1411 aptamer, TTA1 aptamer (binds to the extracellular matrix protein tenascin-C) 
and the RGD peptide (binds to integrin αvβ3). Aptamers have also been conjugated to 
gold nanoparticles (110-112), and super-paramagnetic iron oxide nanoparticles (113,114) 
to obtain enhanced imaging of tumor tissues. Additionally, when anti-cancer agents 
where incorporated with these targeted delivery platforms, it lead to greater antitumor 
activity.  
1.5 Summary 
As discussed above, oligonucleotides are a unique material with excellent 
predictability and reproducibility. By taking advantage of the innate nanoscale precision 
offered by the double helix, it has become one of the most promising scaffolding 
platforms being explored today. In the following chapters, this thesis describes recent 
work in advancing the applications of complex DNA nanostructures for the assembly of 
functional nanomaterials. By minimizing the interference to complex structures, we are 
able to demonstrate excellent spatial and orientation control of cargo attachment to 
simple as well as complex nanostructures, we also report the first successful decoration of 
the tile based DNA tetrahedron, as first reported by Mao et al. We also introduce a “new” 
conjugation chemistry that is likely to find wide adoption within nanotechnology. Using a 
biotin-analogue, we demonstrate the programmable and reversible conjugation of the 
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streptavidin to a DNA origami tile. By enabling multi-step conjugation, it is now possible 
to create dynamic and complex nanostructures. Finally, we explore the use of DNA 
mediated nanoflowers for simple imaging and diagnosis of diseased cells. Nanoflowers 
exhibit high optical scattering properties which are invulnerable to photo-degradation, 
non-toxic, and can be imaged using a standard light optical microscopy set, eliminating 
the need for advanced light sources and filters.  
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1.7 Figures 
 
 
Figure 1.1 Schematic representations of (Top) 4 arm motif, double crossover (DX), and 
triple crossover (TX). (Middle) Design and corresponding AFM images of DNA helix, 
2D crystals, and 3D shapes based on DNA tile designs. (Bottom) Design and 
corresponding AFM images of origami tiles as first described by Rothemund. Adapted 
from reference (40,115,116) 
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Figure 1.2 Recent examples of functionalized DNA origami tiles. (A) RNA and RNA 
hybridization origami “barcodes” for diagnostics and detection of oligonucleotides and 
proteins in solution. (B) Characterization of different single molecule reactions on 
origami tiles by atomic force microscopy. (C) Spatial control of two enzymes (glucose 
oxidase and horse radish peroxidase) to tune the enzymatic cascade reaction rate. The 
spatial control is further characterized by AFM and the rate of product production. 
Adapted from reference (117-119) 
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Figure 1.3 DNA origami tiles decorated with functional nanomaterials. (A) Origami 
directed assembly of carbon nanotubes, characterized by AFM. (B) TEM micrographs of 
origami directed assembly of silver nanopartilces. (C) AFM images of origami directed 
heterogeneous assembly of quantum dots and gold nanoparticles. Adapted from reference 
(120-122). 
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Figure 1.4 Three dimensional origami scaffolds. (A) AFM and TEM characterization of 
origami vessles with complex geometries. (B) Origami folded onto a square lattice. (C) 
“Lego like” orimgai bricks forming a large library of arbitrary three dimensional shapes. 
(D) High yield of three dimensional origami structures by annealing at a constant 
temperature over a short period of time. Adapted from reference (123-126). 
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Figure 1.5 Calculated UV-visible extinction (black), absorption (red), and scattering 
spectra (blue) of Ag nanocrystal in various shapes. (A) Sphere, (B) cube, (C) tetrahedron, 
(D) octahedron, (E) triangular plate, (F) disc. Adapted from reference (127). 
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Figure 1.6 Various demonstrations of aptamer functionalized nanomaterials for directed 
uptake by cancer cells. (A) “Nano-flares” are highly stable DNA functionalized gold 
nanoparticles, used here to deliver a fluorescent probe to the target cell. (B) Highly 
scattering, aptamer functionalized silver nanoparticles uptaken and imaged by dark field 
microscopy. (C) Directed cellular uptake of aptamer functionalized graphene oxide 
nanosheets (GO-nS). Adapted from references (128,129). 
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Figure 1.7 Targeted uptake of functional nanomaterials for multimodal imaging. (Left) 
Aptamer functionalized nanoparticles for multimodal imaging of human breast cancer 
cells. (Right) Mesoporous silica nanoparticles decorated with DNA aptamer for targeted 
uptake by cancer cells with potential to deliver anti-cancer agents. Adapted from 
reference (130,131) 
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CHAPTER 2 
PHOSPHOROTHIOATE MODIFIED DNA FOR SITE SPECIFIC AND 
NANOSCALE 1D HETEROGENEOUS ASSEMBLY  
Portions of this chapter were published as “Controlled Alignment of Multiple Proteins 
and Nanoparticles with Nanometer Resolution via Backbone Modified Phosphorothioate 
DNA and Bifucntional Linkers” Jung Heon Lee, Ngo Yin Wong, Li Huey Tan, Zidong 
Wang, and Yi Lu, Journal of the American Chemical Society 2010, 132, 8906 – 8908. 
Portions of this chapter were published as “Site-Specific Control of Distances between 
Gold Nanoparticles Using Phosphorothioate Anchors on DNA and a Short Bifunctional 
Molecular Fastener” Jung Heon Lee, Daryl P. Wernette, Mehmet V. Yigit, Juewen Liu, 
Zidong Wang, and Yi Lu, Angewandte Chemie International Edition 2007, 46, 9006-
9010 
2.1  Introduction 
 The heterogeneous assembly of nanomaterials to form functional complexes 
represents a significant and rewarding challenge with potential applications in electronics, 
photonics, and medicine. While progress on synthesizing functional nanomaterials with 
well-defined properties, excellent control, and good reproducibility have yielded a 
growing library of nanomaterials, it is unlikely these materials will find wide 
applicability by themselves. Instead, the promise of nanotechnology lies within the ability 
to combine different materials and functions that complement each other in such a way 
that a complete device can be assembled. To that end, traditional top-down lithography 
techniques fall short as it is difficult to produce structures that are capable of assembling 
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heterogeneous materials that have been synthesized. Instead, nanoscience has exploited 
many ways of “self-assembly” techniques to build scaffolds of various complexity, size, 
and control. The basic principle of self-assembly is to take advantage of existing and well 
understood interactions, such as van der Waals forces, hydrophobic/hydrophilic 
interactions, hydrogen bonds, and covalent bonds to predictably control the assembly of a 
final structure.  
 In the early 1950s, a team of researchers revealed for the first time the double 
helix nature of DNA. Soon, the details of Watson-Crick base pairing, as well as the many 
different structures of DNA were revealed through detailed analysis. It is now known that 
the double helix is formed by two anti-parallel strands which hybridize through Watson-
Crick base pairing and base stacking. Structurally, the most common form of DNA under 
cellular and biological conditions is B-form DNA, characterized by a double helical 
structure with a pitch of 3.4 nanometers, a radius of 1 nanometer, 0.34 nanometers per 
nucleotide, and 10.5 bases to form a complete rotation of the helix. While the biological 
role of DNA is complex, its main function is the storage and transfer of genetic material, 
an idea summarized by the basic dogma of biology which tells us that “DNA makes RNA 
makes proteins.” But with the advances in artificial DNA synthesis techniques over the 
past two decades, labs and companies are now able to synthesize short DNA strands (up 
to roughly 100 base pairs) of arbitrary sequence via a solid synthesis technique where 
each base is added to a growing strand in a step wise manner. These capabilities have 
enabled materials scientists and other non-biologist to look at DNA as a biopolymer with 
unique and desirable features for self-assembly applications. As a building material, 
DNA can be treated as both a rigid material (the persistence length of a double stranded 
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DNA is roughly 50 nanometers, where persistence length (P) is a measurement of 
stiffness of a polymer and at lengths below the persistence length, a polymer can be 
treated as a flexible elastic rod) or highly flexible (as a single stranded DNA). 
Additionally, extensive work has contributed to a vast and growing library of 
commerically available non-natural nucleotides that can incorporate novel functionalities. 
One of the largest collections of modified bases can be found at 
http://www.glenresearch.com and commercially synthesized oligos can be purchased 
from http://www.idtdna.com and http://www.trilinkbiotech.com. These functionalities 
include conjugation/ligation chemistries, photo-liable groups, as well as protection 
groups that increase the stability of DNA in the presence of endo- and exo- nucleases. 
The ability to control intra-strand chemistry on a base-by-base basis offers true nanoscale 
manipulation with a theoretical resolution of 0.34 nanometers. 
 With well-defined structural characteristics, a vast library of chemical 
modifications and unnatural bases, and a simple rule for highly specific hybridization, 
Professor Nadrian Seeman was the first to propose the use of DNA strands as the 
building blocks for a highly programmable three dimensional scaffold. As a protein 
crystallographer, Professor Seeman proposed that a simple, repeating molecule such as 
DNA can be easily designed to form repeating two (1,2) and three-dimensional crystals 
(3) that would in turn serve as a scaffold for hard to characterize proteins. Since his 1982 
seminal paper describing the first DNA motifs (4), Prof. Seeman and his colleagues have 
designed increasingly sophisticated structural motifs, such as the double- and triple- 
crossover (5-7), to increase the stability of formed DNA structures and build upon a 
growing library of realized structures. (8) 
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 One important consideration of using self-assembled DNA structures as a scaffold 
for the assembly of nanomaterials is the conjugation chemistry, or the link between the 
nanomaterial and the scaffold. The most common conjugation technique with DNA is 
known as the “sticky end,” where end modified, complementary single stranded DNA are 
attached to two or more components and assembled through sequence specific 
hybridization. (9-11) While this technique has found extensive applications in assembly 
nanoparticles for different applications, the minimum number of hybridized bases 
required for thermal stability (at or around room temperature) is roughly 6 bases, 
therefore end modified DNA sequences cannot be used to explore single base resolution 
patterning. To overcome this problem, researchers have also modified the DNA bases, 
such as biotin-dT, to introduce functional groups inside the strand.(12,13) However, this 
modification significantly disrupts the Watson-Crick base pairing of DNA and 
dramatically inhibits the formation of more complex nanostructures. In order to reduce 
base pairing disruptions, proteins have also been conjugated by introducing functionality 
with enzymes (14) or in the minor grove of DNA by using polyamide conjugates.(15,16) 
The used enzyme requires specific DNA sequence for the method to work, restricting the 
position where protein can be placed. Researchers (12,13) have also demonstrated the 
assembly of nanoparticles into one and two dimensional structures through the use of 
nicks to extend sticky ends from the structure. By reducing the number of hybridized 
base pairs, this strategy is also prone to thermally unstable structures.  
 In order to demonstrate control over intra-strand chemistry without significant 
disruptions to the stability of the double helix, we turn to the sugar-phosphate backbone. 
Phosphorothioate modification (or S-oligos) is a variant of DNA where one of the two 
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non-bridging oxygen atoms has been converted to a sulfur atom. This chiral modification 
was originally explored for its ability to significantly increase the stability of DNA for in 
vitro and in vivo applications where DNA is quickly degraded by endo- and exo- 
nucleases such as POL1 exonuclease, nucleases S1 and P1, serum nucleases, and snake 
venom phosphodiesterase. Shaw et al. (17) showed that the half-life of DNA in serum 
increased from roughly three hours to greater than 7 days by replacing a diester bond 
with a thioate. In the same year, Conway (18) demonstrated the reactivity of the 
phosphorothioate moiety by attaching a small molecule dye, monobromobimane to the 
backbone. By labeling the oligos with multiple dyes, they reported that DNA containing > 
1000 bases pairs can be visualized without the use of electronic equipment with a 
detection limit in the low to sub-femtomolar range. Fidanza et al. (19) reported in the 
subsequent year the conjugation of haloacetamid, aziridine sulfonamide, and unsaturated 
carbonyl to the phosphorothioate diester. The conditions highlighted in this report formed 
the basis of sequence design and reaction conditions described later in this chapter. In the 
report, Fidanza also reported that DNA sequences with a single modification, the thermal 
stability of the DNA duplex is generally very similar to unmodified DNA, subsequent 
reports identified a decrease of melting temperature decrease of 1 – 2 °C per 
phosphorothioate modification. Finally, at roughly $10 per base modification, PS 
modification is one of the most economical modifications available commercially.  
Phosphorothioates are made by two principal routes: by the action of a solution of 
elemental sulfur in carbon disulfide on a hydrogen phosphonate, or by the more recent 
method of sulfurizing phosphite triesters with either tetraethylthiuram disulfide (TETD) 
or 3H-1, 2-bensodithiol-3-one 1, 1-dioxide (BDTD). The latter methods avoid the 
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problem of elemental sulfur's insolubility in most organic solvents and the toxicity of 
carbon disulfide. The TETD and BDTD methods also yield higher purity 
phosphorothioates. 
 In the first demonstration to functionalize PS-DNA with nanomaterials and 
assemble nanoparticles into a 1D assembly with nanoscale distance control, a previous 
student in the lab, Dr. Jung Heon Lee, modified a 100 base pair DNA strand with 
multiple PS sites as anchor points for gold nanoparticles (AuNP). After confirming that 
the PS/thiol moiety was not sufficiently reactive to bind directly to the nanoparticle, a 
short bifunctional linker (BF) was synthesized. The BF has an alkane thiol group at one 
end that can bind to an AuNP and an iodoacetamide group at the other end that can bind 
to a phosphorothioate group on a modified DNA backbone. This method can place 
nanomaterials at any selected backbone site of the DNA structure, making it possible to 
precisely control the position of the nanoparticles along DNA and the distances between 
them, without the need to functionalize AuNPs with a large number of DNA molecules 
(20,21) or purify monofunctionalized nanomaterials.(22-24) In the report, Lee and 
coworkers were able to control the distance between two AuNP from 60 base pairs to 80 
base pairs, corresponding to roughly 20.4 to 27.2 nanometers, respectively, on a 100 base 
pair double stranded DNA template. (25) 
 After successfully demonstrating the feasibility of an iodoacetamide bifucntional 
linker to conjugate AuNPs to a DNA template, we were interested in extending the 
versatility of this technique to other functional nanoscale materials such as proteins. 
Designed and synthesized by nature, proteins are diverse and often exhibit a multitude of 
functions, ranging from fluorescence to catalytic reactions. While their applications in 
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ensemble solution state have been well established, precise control of protein molecules 
in nanometer scale distances and their alignment have been explored only recently.1 
Complex protein assemblies hold great promise in proteomics, nanoelectronics, and 
photonics. In the current work, we synthesize two new bifunctional linkers to incorporate 
biotin and maleimide to conjugate with streptavidin and a cysteine modified myoglobin, 
respectively. Additionally, we extended the number of proteins modified to three from a 
two, as previously reported. Conjugation yield was determined by gel shift assay as well 
as scanning electron microscopy (SEM) through the use of streptavidin modified gold 
nanoparticles.  
2.2  Results and Discussions 
Here, we propose that by modifying the linker chemistry, this technique can be 
used to conjugate different types of proteins on DNA with nanoscale distance control. 
First, we demonstrated conjugation of streptavidin (STV, 52.8 kDa) and cysteine 
modified myoglobin (S35C-Mb, 16.7 kDa) on DNA using biotin and maleimide 
bifunctional linkers (biotin-BL and maleimide-BL). By introducing multiple linkers on a 
dsDNA, we could conjugate multiple proteins on a single dsDNA without nick. 
Furthermore, we showed that the conjugated proteins maintain their activity by binding 
biotinylated AuNPs onto preassembled STV-dsDNA complexes, resulting in AuNP 
dimers and trimers with controlled distances.  
More importantly, through melting temperature study, we demonstrate that our 
backbone modified PS DNA system is much more stable than base modified system 
placed in the middle of a dsDNA strand after protein conjugation. In order to conjugate 
39 
 
STV onto DNA, we used biotin-BL containing an iodoacetamide group on one end and a 
biotin on the other (Figure 2.1). For the conjugation of any protein with an available 
cysteine, we synthesized a linker with maleimide (maleimide-BL). As a model protein 
containing cysteine on its surface, we used a sperm whale myoglobin protein with a 
cysteine mutation introduced onto the surface (Figure 2.2; see experimental details). 
After synthesis of the two bifunctional linkers (see experimental details), the 
linkers were characterized by electron spray ionization mass spectroscopy (ESI-MS) and 
the conjugation products after reaction with 3PS-DNA were characterized by matrix 
assisted laser desorption / ionization mass spectroscopy (MALDI-MS).  Figure 2.3 shows 
the results of the biotin bifunction linker synthesis with a major product peak at 468 MW 
and a +24 peak that correlates well with the linker associated with a sodium atom. After 
reacting with an oligonucleotide that has three consecutive phosphorothioate 
modifications, MALDI-MS shows a distribution of DNA strands with one, two, or three 
modifications, with a high percentage of strands having at least one conjugated linker. 
Interestingly, there is a peak corresponding to a 3PS-DNA with 4 attached linkers. Since 
the sequence was ordered from IDT without gel or HPLC purification, this is likely due 
to adjacent sites unintentionally modified to PS from PO during synthesis. The biotin 
modified sequences are then used without further purification. This characterization is 
repeated for the synthesized maleimide bifucntional linker. Of particular note, the 
maleimide group is liable to degradation via hydrolysis, the linker was synthesized under 
dry / argon conditions, using dry reagents whenever possible. Figure 2.4 shows the 
various characterization of the linker via ESI-MS and the 3PS-DNA linker conjugate by 
MALDI-MS. It is observed that a majority of the strands were functionalized with at least 
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one maleimide linker, without significant degradation. The maleimide linker is also used 
without purification and often within two days of synthesis to avoid degradation. 
To demonstrate the activity of the newly functionalized PS-DNA strands, we 
incubate each bifunctionalized linker functionalized DNA strand with the corresponding 
protein of interest. Figure 2.5 shows a gel shift assay (10% native PAGE) of the resulting 
protein conjugates with single stranded DNA strands. Due to the small size of the 
bifunctional linkers, we cannot observe a structural difference (as characterized by the 
difference in distanced traveled through the gel matrix) between the modified and 
unmodified 3PS-DNA strands (lane 1, 2, and 4). However, lane 3 shows a discreet, 
significantly higher molecular weight when the maleimide modified PS-DNA is reacted 
with S35C myoglobin, indicating the formation of a discreet conjugate. Lane 5 of the 
same figure shows the interaction between a biotin functionalized 3PS-DNA with 
streptavidin. With a molecular weight of 52.8 kDa and a conjugate molecular weight of 
59.0 kDa, it can be observed that a discreet, high molecular weight conjugate was formed 
upon the reaction. Notably, the larger streptavidin-DNA conjugate traveled a smaller 
distance through the polyacrylamide matrix than a corresponding myoglobin-DNA 
conjugate (expected molecular weight of 16.7 kDa, combined molecular weight of 22.9 
kDa), positively confirming the correct formation of desired conjugates.  
Next, we further investigate the interaction between both BL treated PS-DNAs 
and proteins, biotin-BL-ssDNA and maleimide-BL-ssDNA was treated with STV and 
S35C-Mb, respectively, and the mixtures were purified with native 4-20% 
polyacrylamide gel electrophoresis (PAGE) (Figure 2.6). The result confirms the 
conjugation of streptavidin to biotin-BL-ssDNA (~59 kDa, lane 3) and cysteine modified 
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myoglobin to maleimide-BL-ssDNA (~23 kDa, lane 5). When two complementary 
ssDNA containing biotin-BL and malemide, respectively, were hybridized and interacted 
with both proteins, even larger heteroprotein structure (~82 kDa, lane 7) was obtained. 
This indicates that two different proteins can be conjugated on a single dsDNA strand.   
Since multiple PS modifications can be introduced at any desired places on a 
DNA backbone, we sought to use the PS-DNA to control the numbers and positions of 
protein conjugated on a DNA strand. To demonstrate the controllability, 100 bps dsDNAs 
(~34 nm) with 1-3 binding sites (BSs, each site contains triple biotin-BLs labeled on 
three adjacent PS modifications) were reacted with STV and purified with native 4-20% 
PAGE (see Fig. 2). Fluorescein labeled STV (STV-FITC) was used to track their position 
separately from DNA. As shown in lanes 1-4, if a DNA with at least one BS reacts with 
STV, identical band appears on both Fig. 2A and B, indicating the formation of STV and 
dsDNA conjugate. In contrast, control samples without PS modification showed 
negligible interaction between the biotin-BL and DNA (lanes 5 and 6). More importantly, 
as the number of BS placed on the DNA increased from 0 to 1, 2, or 3, a series of 
increasing higher molecular weight bands were formed (Lanes 1-4). This result suggests 
that as the number of BS placed on the DNA increases, the number of STV conjugated on 
DNA increases as well. Interestingly, even though the DNA strands with identical length, 
sequence, and number of BSs were used to conjugate STV, as the distance between the 
two BSs placed on DNA varies from 80 bps (2BS-dsDNA (80)) to 50 bps (2BS-dsDNA 
(50)), the positions of the band of two STV-DNA conjugates are different. We attribute 
the distinct positions of the bands to different conformation of the complexes or possible 
bending of DNA after conjugation with protein. 
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For practical applications, the stability of protein-dsDNA conjugate is important. 
Under identical conditions (5 mM phosphate, 10 mM NaCl buffer, pH 7), the STV-
dsDNA conjugate with biotin-BL and PS modification had the melting temperature ~17 
oC higher than that with biotin-dT. This surprising difference strongly suggests that 
protein-DNA conjugates formed by PS modifications and BLs have higher stability than 
those formed by modified bases. 
Once attached to DNA, it is important for the proteins to maintain their activities 
so that the protein-dsDNA complex is available as a template for other functions. To 
demonstrate such an activity, biotinylated AuNPs were treated with STV and 100 bps 
dsDNA conjugates pre-immobilized on silicon surfaces. Figure 2.7 shows electron 
microscope image of AuNP trimers formed on STV-3BS-dsDNA templates. A large 
portion of AuNPs formed trimers with average distance of ~13 nm which is close to the 
predicted distance of ~14.3 nm. To show distance control, 2BS-dsDNA (80) and 2BS-
dsDNA (50) with the binding sites separated by 80 and 50 bps were used. Average 
distances between AuNPs of dimers were ~26 and ~16 nm, respectively, which is close to 
the predicted distances between the two binding sites of 2BS-dsDNA (80) (~27.2 nm) 
and 2BS-dsDNA (50) (~17 nm). Without PS modification, only a few AuNPs were 
observed. These results suggest that STVs can indeed bind to DNA templates and form 
trimers and dimers with controlled distances.    
2.3 Conclusions 
The current work represents a successful proof of concept demonstrating the 
feasibility of using backbone modified phosphorothioate DNA as anchor points for 
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nanomaterials via engineered bifunctional linkers. We demonstrate the synthesis of three 
novel linkers that incorporates thiol, a biotin, and a maleimide group to the PS-DNA 
backbone that is then subsequently used to conjugate additional nanoparticles or proteins. 
We also demonstrated that the stability of a biotin moiety introduced onto the backbone 
of a double helix molecule is higher than a similar moiety introduced via a modified base. 
We also show the excellent spatial resolution offered through PS-DNA by controlling the 
spacing between gold nanoparticles separated by a programmed number of bases and 
verifying the distance control by scanning electron micrographs. Finally, we 
demonstrated the versatility of the technique by expanding the library of bifucntional 
linkers to include chemistry for protein conjugation. In particular, we demonstrated by 
introducing a surface thiol on a protein (cysteine modification), any protein can be 
theoretically conjugated to the DNA double helix. Looking ahead, there is a tremendous 
library of available conjugation chemistries that can be introduced to the DNA backbone 
via the phosphorothioate modification. In the following chapters, we will explore one of 
the main advantages of the PS-modification: minimal loss of double helix thermal 
stability (i.e. melting temperature) that will enable the modification of complex DNA 
structures.  
2.4 Experimental Details 
Oligonucleotides used in the work were purchased from Integrated DNA 
Technologies Inc. (Coralville, IA). The detailed sequences and information of the DNA 
strands are listed below. N-(+)-biotinyl-3-aminopropylammonium trifluoroacetate, N-(2-
Aminoethyl)maleimide trifluoroacetate, and iodoacetic anhydride used for synthesis of 
biotinylated and maleimide containing bifunctional linker syntheses were all ordered 
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from Sigma-Aldrich (catalog number (CN): 71776, 56951, 284262). Unconjugated and 
FITC modified streptavidins were purchased from Invitrogen (CN: SNN1001) and 
Sigma-Aldrich (CN: S3762), respectively. 15% and 4-20% Ready Gel Tris-HCl Gel, used 
to separate DNA-protein conjugates from unreacted DNA and proteins, were obtained 
from Bio-Rad. (CN:161-1157 and 161-1159) N-(trimethoxysilylpropyl)ethylenediamine, 
triacetic acid, trisodium salt, 45% in water used to form layers of carboxyl group on Si 
substrate was purchased from Gelest, Inc. (CN: SIT8402.0) EDC (N-(3-
Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride) and NHS 
(Nhydroxysuccinimide) used for the attachment of DNA on Si surface were obtained 
from Sigma Aldrich (CN: E6383) and Fluka (CN: 08975), respectively. 5 nm biotinylated 
gold nanoparticles were ordered from NanoCS Inc. (CN: GNB5) P type doped Si wafers 
(〈100〉, 0.01–0.02 ohm-cm) used for AuNP assembly imaging were purchased from 
Montco Silicon Technologies (CN: S5935). 
DNA sequences 
Name  Sequence 
0PS-20bp DNA 5' - GGC GTT CAC AAG GTC TGC AC - 3' 
1PS-20bp DNA 5' - GGC GTT C*AC AAG GTC TGC AC - 3' 
3PS-20bp DNA 5' - GGC GTT* C*A*C AAG GTC TGC AC - 3' 
2PS-20bp DNA 5' – GGC* G*TT CAC AAG GTC TGC AC - 3' 
0PS-20bp DNA-
comp 5' - GTG CAG ACC TTG TGA ACG CC - 3' 
2PS-20bp DNA-
comp 5' - GTG CAG ACC TTG TGA AC*G* CC - 3' 
3IntBiot-20bp DNA 5' - GGC GT Biotin-dT Biotin-dT Biotin-dT C AAG GTC TGC AC - 3' 
IntBiot-20bp DNA-
comp 5' - GTG CAG ACC TTG AAA ACG CC - 3' 
Biotin-20bp DNA 5' - Biotin-GGC GTT CAC AAG GTC TGC AC - 3' 
Biotin-20bp DNA-
comp 5' - Biotin-GTG CAG ACC TTG TGA ACG CC - 3' 
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0PS-100bp Anchor 
DNA 
5' - GGC ATG GTC TAC GTC ACC CTA GTC AGT CAT 
CTT GCA CTA TCT CCT TGA GAA CGT CAC GCG TCA 
GTA CGC TAC ATC TTA CAC CAG CAC TAC GTC ACA 
CCT A - 3' 
 
1BS-100bp Anchor 
DNA 
5' - GGC ATG GTC TAC GTC ACC C*T*A* GTC AGT 
CAT CTT GCA CTA TCT CCT TGA GAA CGT CAC GCG 
TCA GTA CGC TAC ATC TTA CAC CAG CAC TAC GTC 
ACA CCT A - 3' 
2BS-100bp Anchor 
DNA (80) 
5' - GGC ATG GTC* T*A*C GTC ACC CTA GTC AGT 
CAT CTT GCA CTA TCT CCT TGA GAA CGT CAC GCG 
TCA GTA CGC TAC ATC TTA CAC CAG CAC TA*C* 
G*TC ACA CCT A - 3' 
2BS-100bp Anchor 
DNA(50) 
5' - GGC ATG GTC TAC GTC ACC C*T*A* GTC AGT 
CAT CTT GCA CTA TCT CCT TGA GAA CGT CAC GCG 
TCA GTA CGC* T*A*C ATC TTA CAC CAG CAC TAC 
GTC ACA CCT A - 3' 
3BS-100bp 
Anchor DNA 
5' - GGC ATG GTC T*A*C* GTC ACC CTA GTC AGT 
CAT CTT GCA CTA TCT CCT TGA GAA C*G*T* CAC 
GCG TCA GTA CGC TAC ATC TTA CAC CAG CAC TAC 
GTC A*C*A* CCT A - 3' 
100bp comp DNA 
5' - TAG GTG TGA CGT AGT GCT GGT GTA AGA TGT 
AGC GTA CTG ACG CGT GAC GTT CTC AAG GAG ATA 
GTG CAA GAT GAC TGA CTA GGG TGA CGT AGA CCA 
TGC C - 3' 
Amine-30T-100bp 
comp DNA 
5' - Amine- TTT TTT TTT TTT TTT TTT TTT TTT TTT 
TTT TAG GTG TGA CGT AGT GCT GGT GTA AGA TGT 
AGC GTA CTG ACG CGT GAC GTT CTC AAG GAG ATA 
GTG CAA GAT GAC TGA CTA GGG TGA CGT AGA CCA 
TGC C - 3' 
 
Bifunctional linker synthesis. N-(+)-biotinyl-3-aminopropylammonium 
trifluoroacetate was dissolved in 0.1 N NaOH to get 32 mM solution. Also iodoacetic 
anhydride was dissolved into 1,2 dichloroethane to get 0.22 M solution. Both solutions 
were mixed in 4:1 ratio and agitated using a vortex mixer for a minute to get white 
precipitate. The solution was centrifuged at about 10,000g for 15 minutes. Since the 
product is not soluble in either water or 1,2 dichloroethane, the precipitate can be 
removed from the solvent. In order to separate by-products and reagents from the product, 
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water was added to the precipitate followed by vortex, centrifugation, and supernatant 
removal. The process is repeated with acetone to remove unreacted iodoacetic anhydride 
from the product. The solvent is evaporated and Biotin-BL is stored in powder form. 
Maleimide-BL synthesis.To a mixture of iodoacetic anhydride (0.28 mmol), N-(2-
Aminoethyl) maleimide trifluroacetate salt (0.10 mmol), and DCM (2.5mL) was added 
NEt3 (0.028 mmol) dropwise. After stirring at room temperature for 1 hr, the reaction 
was washed with saturated NaHCO3 (2 x 1mL) and saturated NaCl (1 x 1 mL). The 
organic layer was dried (Na2SO4), and further dried under vacuum. The product is 
dissolved in DMSO before use. 
Reaction between PS-DNA and bifunctional linkers. Biotin-BL was dissolved in 
DMSO so that the concentration becomes 100 mM. For DNA with one phosphorothioate 
modification, Biotin-BL in DMSO and phosphorothioate modified DNA in S4 buffer is 
mixed in the ratio of 200 to 1 in DMSO/water 1:1 solution. The reaction can be made at 
30 oC for 5 hours. (Caution: Biotin-BL can be degraded in DMSO in a few days. So it is 
suggested to dissolve Biotin-BL in DMSO right before use). 
DNA preparation and hybridization. 20bp dsDNA: Two complementary DNA 
strands were mixed in 20 mM phosphate (pH 7) / 100 mM NaCl and kept at room 
temperature for about an hour for hybridization. The concentration of DNA is 8 μM. 
100bp dsDNA: Biotin-BL-3BS-dsDNA, Biotin-BL-2BS-dsDNA (80), Biotin-BL-
2BS-dsDNA (50), and 0BS-dsDNA were prepared by hybridizing two complementary 
DNA strands in 20 mM phosphate (pH 7), 50 mM NaCl buffer at room temperature for 
about an hour. The concentration of DNA is 1.5 μM. Amine-30T-100bp comp DNA was 
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used instead of 100bp comp DNA for immobilization of DNA on carboxyl group 
modified on Si surface. 
Gel electrophoresis. 15% Ready Gel (Tris-HCl Gel) was used to separate 20bp 
dsDNA conjugated with STV-FITC from unreacted dsDNA and STV. 8 μM of dsDNA 
and 48 μM of STV were mixed for STVdsDNA conjugation. STV-dsDNA reaction was 
made for 1.5 hrs before running gel. 4-20% Ready Gel (Tris-HCl Gel) was used to 
separate 100bp dsDNA conjugated with multiple STV-FITCs from unreacted dsDNA and 
STV-FITC. The concentration of DNA was adjusted to 300 nM and STV-FITC was 
added afterwards (27 μM) for STV-dsDNA conjugation. STV-FITC was used in excess 
to prevent crosslinking of STV and dsDNA. STV-dsDNA reaction was made for 1.5 hrs 
before running gel. 50 mM Tris acetate buffer (pH 7.2) was used as running buffer. As 
STV has isoelectric point (pI) around 5.5, it is negatively charged with about two electron 
charges at pH 7.2 (3) and it can migrate through gel with DNA as well. The concentration 
of STV was calculated based on the reported extinction coefficient of 41820 L mol-1cm-
1 at 280 nm. 
Melting temperature experiments. After 20bp dsDNA (0PS-dsDNA, 3PS-dsDNA, 
Biotin-dsDNA, Biotin-3dT-dsDNA, see Table S2) was hybridized and prepared based on 
the procedure mentioned above, the STV-dsDNA conjugate was formed by adding 4 eq. 
of STV into DNA solution. Afterwards the concentrations of phosphate and NaCl were 
adjusted to 5 and 10 mM, respectively. The temperature was controlled from 4 oC to 60 
oC with 2 min interval between each temperature. HP 8453 UV-vis S5 spectrometer was 
used to collect absorbance variation at 260 nm. 
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AuNP attachment on STV-dsDNA templates. After piranha solution treatment 
and thorough washing, Si substrates were incubated in 0.45 % N-trimethosysilylpropyl) 
ethylenediamine, triacetic acid, sodium salt solution (0.5 mL of 45% solution was diluted 
in 50 mL of deionized water) for 12 hours to form multilayers of carboxyl groups on Si 
surface. The Si surface was thoroughly washed afterwards. In order to immobilize DNA 
on Si surface, 100bp dsDNA (3BS-dsDNA, 2BS(80)-dsDNA, 2BS(50)-dsDNA, and 
0BS-dsDNA) was first prepared and hybridized following the process mentioned above. 
In this case, Amine-30T-100bp comp DNA (containing amine group on 5’end of the 
strand linked by 30T) was used instead of 100bp comp DNA to provide flexibility to 
dsDNA on the surface. After incubating carboxyl group modified Si substrate into DNA 
solution, 11 volume % of NHS solution (16.5 mg dissolved in 2.5 mL deionized water) 
was added to the DNA solution. Eleven volume % of EDC solution (33 mg dissolved in 
2.5 mL deionized water) was added immediately afterwards and the reaction was kept for 
an hour. The Si substrates were washed with 25 mM phosphate (pH 7) and 100 mM NaCl. 
To conjugate STV on dsDNA immobilized on surface, Si substrates were 
incubated in 2 μM STV solution in 30 mM phosphate (pH 7) and 400 mM NaCl for an 
hour. The Si substrates were washed thoroughly with 25 mM phosphate (pH 7) and 100 
mM NaCl. 
To assemble AuNPs onto STV-dsDNA templates, Si substrates containing STV 
treated dsDNA were treated with 70 nM 5 nm biotinylated AuNPs solution 25 mM 
phosphate (pH 7) and 250 mM NaCl buffer. The reaction was made for 15 hours. 
Afterwards the Si substrates were washed thoroughly with 25 mM phosphate (pH 7) and 
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25 mM NaCl. The Si substrates were gently washed with deionized water before imaging 
to remove salt on the surface. 
Hitachi S4800 scanning electron microscope was used to take images of AuNP 
trimers and dimers on Si surface. SEM was performed at 10 kV at the working distance 
of about 5 mm. 
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2.6 Figures 
 
Figure 2.1 Schematic and chemical structure of the double helix DNA and 
phosphorothioate modification on one of the non-bridging oxygens on the DNA sugar 
phosphate backbone. The proposed chemical reaction between an iodoacetamide linker 
and the phosphorothioate modification is illustrated in the enlarged schematic. The 
binding end can be modified for a wide variety of conjugation chemistries.  
 
 
 
 
53 
 
 
Figure 2.2 Chemical structures of the two synthesized bifunctional linkers (biotin and 
maleimide functionalized) as well as the two proteins of interest to this study: 
streptavidin and myoglobin. The bottom shows a representation of the serine (S35) 
mutation to cysteine, thereby introducing a thiol group to the surface of the protein. This 
thiol subsequently reacts with the maleimide linker to form a covalent bond between the 
protein and the DNA scaffold.  
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Figure 2.3 Chemical structure of the synthesized biotin bifunctional linker. The synthesis 
is confirmed via time-of-flight mass spectrometry where a correct mass of 468 was 
observed. (Right) After reacting with a DNA strand with 3 consecutive phosphorothioate 
modifications, the product was characterized using matrix assisted laser 
desorption/ionization mass spectroscopy (MALDI-MS). Peaks corresponding to the 
original, unmodified strand, as well as those corresponding to 1, 2, and 3 conjugated 
biotin linkers were observed.   
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Figure 2.4 Chemical structure of the synthesized maleimide bifunctional linker. The 
synthesis is confirmed via time-of-flight mass spectrometry where a correct mass of 307 
was observed. (Right) After reacting with a DNA strand with 3 consecutive 
phosphorothioate modifications, the product was characterized using matrix assisted laser 
desorption/ionization mass spectroscopy (MALDI-MS). Peaks corresponding to the 
original, unmodified strand, as well as those corresponding to 1, 2, and 3 conjugated 
maleimide linkers were observed.   
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Figure 2.5 Gel shift assay under native conditions. (Lane 1) Original, unmodified DNA 
strand. (Lane 2) Single stranded phosphorothioate modified DNA (ss-PS-DNA) with 
biotin-bifunctional linker. (Lane 3) Biotin functionalized PS-DNA incubated with 
streptavidin. (Lane 4) Single stranded phosphorothioate modified DNA (ss-PS-DNA) 
with maleimide-bifunctional linker. (Lane 5) Maleimide functionalized PS-DNA 
incubated with myoglobin. 
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Figure 2.6 Gel shift assay under native conditions. (Lane 1) Double stranded 
phosphorothioate modified DNA (ds-PS-DNA). (Lane 2) ds-PS-DNA with biotin-
bifunctional linker. (Lane 3) ds-PS-DNA with biotin-bifunctional linker incubated with 
streptavidin. (Lane 4) Maleimide functionalized ds-PS-DNA. (Lane 5) Maleimide 
functionalized ds-PS-DNA incubated with myoglobin. (Lane 6) Hybridized product of ss-
PS-DNA with biotin/streptavidin and ss-PS-DNA with maleimide/myoglobin.  
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Figure 2.7 Multiple STV attachment onto 100 base-paired dsDNA, demonstrated by native 
PAGE. Images of (A) fluorescein labeled STV (excit = 473 nm and em = 520 nm) and (B) EtBr 
treated DNA (excit = 530 nm and em = 580 nm) after conjugation. Both gel images are taken 
from the identical gel, but at different excitation and emission wavelengths. Lanes 1-5: 3BS-
dsDNA [3 binding sites (BS) on DNA with 42 bps distances], 2BS-dsDNA (80) [2BSs on DNA 
with 80 bps distance], 2BS-dsDNA (50) [2BSs on DNA with 50 bps distance], 1BS-dsDNA 
[1BS on DNA], and Biotin-BL treated 0BS-dsDNA [no BS on DNA] treated with STV. Lane 6: 
Biotin-BL untreated 0PS-dsDNA with STV. Lane 7 and 8: Unreacted STV and 0BS-dsDNA, 
respectively. Once dsDNA bind to STV, the conjugate should be observed in both gel 
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CHAPTER 3 
ASSEMBLY ON COMPLEX DNA NANOSTRUCTURES WITH 
ADVANCED CONTROL AND PRECISION 
Significant portions of this chapter were published as “Site-Specific Attachment of 
Proteins onto 3D DNA Tetrahedron through Backbone-Modified Phosphorothioate DNA” 
Ngo Yin Wong, Chuan Zhang, Li Huey Tan, and Yi Lu, Small 2011, 7, 1427 – 1430. 
3.1 Introduction 
In chapter one, we introduced and demonstrated the feasibility of 
phosphorothioate modified DNA backbones as a one dimensional template for patterning 
nanomaterials such as nanoparticles and proteins with excellent resolution and minimal 
disruption to the stability of the double helix structure. To explore this idea further, we 
hypothesize that the PS modification is ideal for enabling the functionalization of 
complex DNA nanostructures, as well as enabling advanced spatial and orientation 
control over the conjugated material. (1)  
As discussed briefly in the introduction of this thesis, there are two main 
strategies to build DNA nanostructures, the DNA tile methods and the origami method. 
The DNA tiles is designed and assembled from a small number of short DNA oligos, 
usually less than 4 strands of roughly 30-60 base pairs. These short oligonucleotides are 
designed such that they form double crossover (DX) or triple crossover (TX) structures, 
desigsn that significantly increased the rigidity of artificial DNA structures and advanced 
the field of structural DNA nanotechnology and is worthwhile of a brief discussion here. 
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DNA branched junctions were first described by Seeman and coworkers in the 
1980s. (2) The first designs were inspired by the Holliday junction, a transient formation 
that supports genetic exchange in many organisms. By carefully optimizing the sequence 
and length of the arms, Seeman and coworkers were able to stabilize the three and four 
arm junctions, but the rigidity of the tiles remained an issue. If a four arm junction is not 
rigid and where each arm is fixed at right angles from each other, the tiles cannot be 
organized into larger, periodic structures due to angle fluctuations. This was eventually 
solved with the design of the double crossover structure, again by Seeman and coworkers. 
(3) The double crossover consists of joining two adjacent double helixes by a single 
strand that begins on one helix and ends on the adjacent helix. This concept was further 
extended into a triple crossover (TX) and the increase rigidity, along with the 
incorporation of sticky ends, later enabled allowed the growth of large two and three 
dimensional DNA crystals. (4) 
One of the characteristics of using these multi-arm junctions is the lack of control 
over how large the final assembly becomes. Thanks to the symmetric nature of the tiles 
and the sticky ends, with careful design and preparation, Mao et al. have shown that two 
dimensional crystals can growth over 20 microns in length. (5) In order to gain greater 
control over the assembly, Yan et al. demonstrated the assembly of finite arrays through 
the judicious use of sequence symmetry. In an elegant demonstration of “algorithmic 
self-assembly” Winfree et al. (6,7) demonstrated that armed tiles can be used to create 
“Wang tiles” where each tile contains a single “color” on each of the four sides and 
assembles such that the adjacent tile is of the same color. From assembled templates, it is 
easy to imagine the decoration of these structures with different nanomaterials. Indeed 
61 
 
this was extensively explored by Kiehl, Seeman, and Yan, among many others. (8-11) 
Most of these researchers used toe-hold sticky ends as an anchor for the hybridization 
with a complementary strand that is attached to a nanomaterial.  
More interestingly, by introducing additional flexibility at the vertices of these 
tiles, it becomes possible to form discreet three dimensional (3D) polyhedral. In an 
elegant demonstration He et al. (12) demonstrated the assembly of tetrahedral, 
dodecahedra, and buckyballs by controlling the concentration of three arm tiles in a one 
pot process. Other examples of 3D DNA structures include cubes (13), truncated 
octahedral (14), octohedra (15), and tetrahedral (16,17). The DNA tetrahedron described 
by He et al. forms the basis of the work in this chapter. He and coworkers further 
demonstrated structural control by designing and assembly two chiral DNA octahedral by 
taking advantage of the DNA double helix. (18) It is important to note that the 
tetrahedrons described by He (12) and Goodman (16) have significant differences that 
have lead to the higher adoption of Goodman’s tetrahedron. Briefly, He’s tetrahedron 
consists of 4 four-armed tiles that have sticky ends of 6-8 bases. This type of tile based 
assembly requires a long annealing process (24 – 48 hours), careful control of 
concentration (cannot exceed 60 nM), and careful titration of component strands to form 
the tetrahedrons. In contrast, Goodman’s tetrahedron is considerably more simple, 
consisting of only 4 strands, with each strand making up one half of the double helix for 
each side of the tetrahedron. This simple design allows the tetrahedron to form is much 
higher concentrations and with higher yield, as well as a higher tolerance for strand ratios. 
In the following work, we succesfully demonstrate that the phosphorothioate backbone 
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anchor for fucntionalization is compatitble with both tetrahedrons, with the distinction of 
being the first chemistry reported to sucessfully decorate He’s tetrahedron. 
While there have been many excellent reports of assembly of proteins on a 2D 
scaffold, there has been significantly fewer reports of assembly on a 3D scaffold. Xibo et 
al. (19) described a “quasi-3D” structure by first assembling AuNPs on a 2D origami 
surface and subsequently rolling the structure into a 3D plasmonic structure with the 
introduction of additional staple strands. In one of the first demonstration of decoration of 
a 3D structure, Erben and coworkers (20) showed the encapsulation of a 12.4 kDa 
cytochrome c within a simple tetrahedron structure. The tetrahedron consists only of 4 
unique strands and is smaller than the structure described previously. However, relaxed 
stoichiometric ratio requirements and a high assembly yield without the need for 
purification has fueled the popularity of this structure among researchers, with several 
recent publications by Walsh (21), Schueller (22), and Lee (23), demonstrating their in 
vitro applications. In one of the most complete in vitro and in vivo demonstrations of 
DNA nanostructures of diagnosis and therapy applications, Lee (23) highlighted the 
homogenous size, composition, and surface chemistry of DNA nanostructures. DNA 
structures also offer flexibility in size control as well as site-specific, asymmetric 
functionalization. Finally, taking advantage of the increased stability of DNA structures 
versus individual double stranded and single stranded DNA in serum and biological 
fluids, Lee and coworkers demonstrated targeted delivery of siRNA for gene silencing in 
in tumor xenograft mouse models via functionalized DNA tetrahedrons. Interestingly, 
they reported the optimal number of folate (as targeting agent) to be three, with no 
improvement in gene silencing with increasing numbers of folate. However, by 
63 
 
orientating the direction of each folate modification, they were able to see an increasing 
in gene silencing by orienting the targeting ligands in the same direction.  
More recently, reports of in vivo fabrication of DNA structures were reported. Lin  
et al. (24) successfully incorporated sequences to form nanostructures into XL1-Blue 
cells and subsequently produced in high numbers by the cell.  Delebecque and coworkers 
(25) reported the design and assembly of one and two dimensional RNA structures that 
assembled proteins in the hydrogen producing pathway and demonstrated that the 
presence of the scaffold proportionally increased the production of hydrogen.  
3.2 Results and Discussions 
For the current work, we chose to work with a 3 armed DNA motif, first proposed 
by He et al., that can form large, repeating hexagonal structures in the 2D or modified 
slightly to form a simple tetrahedron 3D cage. (12) Since both structures can be formed 
by the specific hybridization of 3 different strands of DNA, our strategy involves the 
functionalization of the “central” strand of the motif with phosphorothioate modifications 
on the DNA backbone. As will be described below, we designed a soluble version of the 
bifunctional linker to increase stability of the linker during the long anneal process. By 
introducing a biotin on one end of the linker, we are then able to conjugate a single 
streptavidin protein onto each tile, and since four tiles make up each tetrahedron, we 
would in theory be able to attach four proteins onto each tetrahedron. Using this current 
design, it is not possible to control the number of proteins that are conjugated to the 
tetrahedron since each of the vertexes is made up of an identical tile. Later, we utilize a 
different tetrahedron that allowed not only control over the number of protein conjugated 
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to a three dimensional structure, but the orientation of the protein cargo as well. Finally, 
we explore an often overlooked chemistry that allows the simple and effective release of 
the streptavidin cargo from the DNA nanostructures, enabling possible applications for 
DNA structures as nanoscale delivery vehicle for in vitro or in vivo applications.  
Our previous work has confirmed the reaction between the iodoacetamide group 
with a phosphorothioate modification with high yield. PS modified DNA is conjugated 
with biotin linker in 1x TAE-Mg2+ buffer for 5 hours at 50C, the resulting product is 
desalted to remove excess linker molecules. The conjugation yield is greater than 90 
percent as shown by mass spec and gel shift assay and is used without further purification. 
We have also demonstrated that the linker conjugation is thermally stable under the 
annealing conditions necessary to form 2D and 3D structures. 
In the previous demonstration of phosphorothioated modified DNA (PS-DNA) by 
Lee et al., the linker used was a highly hydrophobic bifunctional small molecule that was 
the result of reacting N-(+)-biotinyl-3-aminopropylammonium trifluoroacetate with 
iodoacetic anhydride. The resulting product was almost completely insoluble in water and 
as a result its conjugation to the water soluble PS-DNA was easily prone to hydrolysis 
and degradation. This was a significant barrier as unlike the previous work in which the 1 
dimensional arrays were formed by simply mixing complementary DNA sequences at 
room temperature and allowing the double helix to form, the formation of the DNA 
tetrahedron required heating the DNA strands to 90 °C and allowing it cool slowly over 
48 hours. Mass spectroscopy confirmed that the linker modified DNA cannot survive the 
heating and the thiol is quickly hydrolyzed back into an oxygen atom and the linker is 
removed. One strategy to improve the stability of the linker was by making the 
65 
 
bifucntional linker more water soluble through the introduction of a short polyethylene 
glycol (C-C-O) chain within the linker. In determining the optimal linker, it is important 
to optimize the hydrophilicity of the bifuctional linker while minimizing the length to 
maintain good spatial control. By introducing a “three PEG” spacer in the linker, mass 
spectroscopy data showed that the linker is stable enough to withstand the annealing 
process of the tetrahedron. It is worth noting that a “two PEG” spacer exhibited 
significantly reduced solubility. For details on the synthesis and characterization of the 
biotin-PEG-iodoacetate linker, please see the experimental details later in the chapter.  
The tetrahedron is formed by annealing a long, single circular “central” strand, 
along with two shorter “arm” strands. In designing the tile for formation of polyhedral, 
He et al. introduced 5 non-hybridized tymines that introduce the necessary flexibility to 
bend the tiles inward 60 degrees needed to form the vertices of a tetrahedron. A simple 
simulation of the location of the backbone shows that these bases are ideally suited for 
phosophorothioate modification since the phosphate backbone appears to be facing 
outward at each of the vertices. Also, the non-hybridized nature of the thymine means 
minimal disruption to base pairing and the stability of the structure. This is an important 
point for while these structures have been discovered for more than 4 years, there has yet 
to be a report of decoration of this type of structure with nanomaterials. Finally, the 
availability of three thymine sites (of five available) for phosphorothioate modification 
significantly increases the efficiency of linker binding and finally, the efficiency of 
protein binding as first reported by Lee and coworkers. 
The PS modified central strand was first chemically modified with the 
synthesized biotin polyethyleneoxide iodoacetamide bifunctional linker in 1x TAE-Mg2+ 
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buffer at 50 °C for 5 hours and the excess linker was removed by size exclusion column. 
The conjugation was confirmed by mass spectrometry and the reaction yield was 100% 
after purification (for details, please again refer to experimental details section below). 
The use of non-purified strands resulted in a lower density of protein binding, therefore 
the purification step is necessary to achieve high density of protein conjugation (up to a 
maximum of 4 per tetrahedron) to the final tetrahedron structure.  
After the functionalization of the long central DNA strand with the biotin 
bifunctional linker, individual DNA tiles (without sticky ends to form larger structures) 
were assembled by truncating the shortest arm strand that makes up the tile. The formed 
structures were incubated with streptavidin and characterized by gel shift assay. From the 
gel image, greater than 90% of the formed tiles are able to withstand the annealing 
process and subsequently bind a streptavidin protein to the PS modified DNA strand.  
Assembly of the DNA tetrahedron containing the PS modification and 
bifunctional linker was adapted from a previously reported protocol. (26) Briefly, the 
three DNA strands were mixed at a ratio of (1:3:3) in a Tris-acetic acid-EDTA-Mg2+ 
buffer and the mixture was slowly cooled from 95 °C to 25 °C over 48 hours. The 
assembled DNA structures were characterized by non-denaturing polyacrylamide gel 
electrophoresis (PAGE). As shown in Figure 3.5, only a single band was observed in lane 
1 and 3, suggesting that the PS modified and biotin linker functionalized central strands 
self-assemble with the middle and short strands into a single complex, in good agreement 
with previous reports. In order to keep a strict 1:3:3 ratio between the three sequences, 
the stock DNA is first diluted to the desired concentration as measured by Abs(260 nm) 
using a UV-Vis. Next, titration gels are used to fine tune the ratio between strand 1 and 2 
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as well as between 2 and 3. By varying the volume of one with respect to the other, 
annealing, and separated by 10% PAGE, the volume ratio where either initial strands 
cannot be seen (only higher molecular weight assembly is visible, Figure 3.5 and Figure 
3.6) is determined to be the optimal ratio. For simplicity sake, it is often desired that the 
concentrations of the three strands be set to 3.33x, 10x, and 10x, respectively.  
After determining the precise volume ratio of the three strands, they were 
combined at a final concentration of 60 µM in 1x TAE-Mg2+ buffer and annealed from 
90 °C to room temperature over 2-3 days. The annealing process was done by floating the 
samples in a 2 liter water bath heated to 90 °C and placed in a large Styrofoam box and 
left until the system has cooled to room temperature. After carefully washing the 
annealed structures by centrifugation 3 times, the structures were characterized by native 
PAGE and stored for a maximum of three days at 4 °C until used. 
To form the 3D tetrahedron, the structures are incubated with a solution of 
streptavidin for 2 hours before analysis by native gel shift assay and imaged under fluid 
atomic force microscopy. Figure 3.4 shows the results of a 10% native polyacrylamide 
gel shift assay analyzing the results of a typical tetrahedron assembly without further 
purification. Lane 1 shows the biotinylated PS-DNA strand with a portion associated with 
the streptavidin protein (as evident by the slower moving band, indicating a larger, higher 
molecular weight complex). Lanes 3, 4, and 5 shows a distinct band that corresponds to 
the tetrahedron, the PS-modified tetrahedron, and the biotin linker modified tetrahedron. 
The consistent location of the three bands indicated that the modifications and 
bifunctional linkers did not dramatically alter the shape and size of the tetrahedron. 
However, upon the introduction of streptavidin to a biotin linker modified tetrahedron, 
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the band that corresponded to an unmodified tetrahedron fades and discreet higher 
molecular weight products became visible.  
Figure 3.5 then shows the results of the assembly and conjugation process with 
purified strands. As shown in the lane 3 and 4 of Figure 3.5, the band corresponding to 
the DNA tetrahedron containing PS modification and bifunctional linker fades and four 
discreet bands with higher molecular weights appeared instead. These results suggest 
successful conjugation of one, two, three, and four proteins onto the DNA nanostructure. 
Since the streptavidin protein has 4 binding sites for biotin, the concentration of protein 
added is ~16 times the concentration of tetrahedrons to encourage the binding of multiple 
proteins to a single nanostructure while discouraging the formation of single protein 
bound to multiple nanostructures. While we can achieve 100% conjugation of protein to 
single stranded PS-DNA, (Figure 3.1) the yield of tetrahedron structures modified with 4 
streptavidin was significantly lower than expected. This is likely due to thermal 
degradation and hydrolysis of the biotin linker during the annealing process. 
To further confirm the successful conjugation of protein to the discrete 
nanostructure, the unmodified structure and the band corresponding to tetrahedron with 1 
protein attachment was purified by non-denaturing PAGE, recovered, and imaged using 
alternating current atomic force microscopy (AC-AFM). In the absence of streptavidin, 
the AC-AFM image of the assembled DNA strands containing PS modification and 
bifunctional linker showed well dispersed and uniform structures with a height of 
approximately ~2 nm and a lateral dimension of 25 nm (Figure 3.6). These results are 
similar to what was observed previously reported DNA tetrahedron without the PS 
modification or the bifunctional linker, and are consistent with a collapsed tetrahedron 
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due to its dried state and the tapping force. (26) After incubation with protein, 
nanostructures recovered from the band corresponding to a tetrahedron with one bound 
streptavidin shows structures with an increase in height to ~6 nm, correlating well with 
the addition of a ~4 nm protein onto the tetrahedron. Additional evidence for protein 
conjugation to the DNA tetrahedron scaffold can be obtained from observation of 2D 
structures when the same samples were imaged in fluid, which shows larger, unfolded 
hexagonal arrays formed from 3 point star components of the tetrahedron and selective 
protein attachment to the vertices (Figure 3.7). 
Thermal stability of a PS-biotinylated double strand sequence was previously 
examined. Briefly, a PS-biotinylated DNA conjugated to STV had melting temperatures 
about 17 °C higher than strand with internal thymine biotin in 5 mM phosphate and 10 
mM NaCl but 9.5 °C lower melting temperature then end conjugated streptavidin. This 
suggests that protein-DNA conjugates formed by PS modifications via backbone 
modifications have higher stability than those formed by modified bases. We further 
investigated the stability of PS modified and linker modified tetrahedrons via gel shift 
assay (Figure 3.8). Tetrahedrons, PS modified tetrahedrons, and biotin linker 
functionalized tetrahedrons were formed as described by slowly annealing 3 DNA strands 
slowly from 90 °C in a 1:3:3 ratio in 1x TAE-Mg buffer. The structures were 
concentrated by amicon to 1 µM and incubated at 25 °C for 3 days and characterized by 
non-denaturing gel shift assay.  
Next, we further explore the compatibility of a backbone phosphorothioate 
modification with different DNA nanostructure designs. As mentioned in the introduction 
to this chapter, Goodman et al. (16) demonstrated a small DNA tetrahedron that consists 
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of 4 different strands, which each makes up one-half of the double helix that is each side 
of the tetrahedron. Since the double stranded DNA that makes up each side of the 
tetrahedron maintains its B-DNA formation, it is possible to predict where the backbone 
will be pointed “inside” the tetrahedron and when it will be pointed “outside.” This is an 
advancement over using nicks in the DNA double strand to introduce a sticky end since it 
does not lower the melting temperature of the structure and can, in theory, introduce 
many modifications without disrupting the structure.  
In a simple demonstration of the orientation control of the protein cargo with 
respect to the tetrahedron, we introduced a series of phosphorothioate modifications to 
one side of the simple tetrahedron, functionalized the PS modification with biotin linkers 
as described above, assemble the structure as previously reported by Goodman and others, 
and finally incubated with streptavidin. Figure 3.9 shows the result of this experiment. 
We expect that if the protein is partially or fully orientated inside the tetrahedron, the 
overall dynamic radius will be smaller than if the protein was orientated outside of the 
tetrahedron. This difference can be directly characterized by a native PAGE gel shift 
assay where the distance traveled by the structures within the gel matrix is a function of 
structure size (molecular weight and secondary/tertiary structures) and charge density. 
Assuming the charge density is equivalent between a protein is inside or outside the 
tetrahedron, we can assume that a tetrahedron with a protein partially or fully within the 
structure will travel a greater distance within the gel matrix than a structure with a protein 
protruding from the side. This difference is observed in the PAGE image (Figure XX) 
and fits well with the predicted DNA double helix twist, where a complete rotation is 
repeated every 10.5 bases.  
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Finally, in a demonstration of the potential application of such DNA tetrahedral as 
an in vitro or in vivo delivery vehicle for therapeutic agents, the release of the protein 
from the tetrahedron structure is demonstrated. 
To facilitate the release of streptavidin from the structure, we took advantage of a 
biotin-analogue, desthiobiotin, which exhibits a 1000 times lower binding affinity to 
streptavidin then biotin. A deeper discussion into desthiobiotin and linker design will be 
presented in the following chapter. Here, it remains suffice to mention that by replacing 
the biotin moiety on the bifuncitonal linker with a desthiobiotin, the streptavidin can bind 
to desthiobiotin but in the presence of a sufficient concentration of biotin, the 
desthiobiontin  is competitively replaced and leads to the release of the protein from the 
tetrahedron. Figure 3.10 shows a gel shift assay of a tetrahedron structure prepared with 
desthiobiotin modified linkers at the same PS sites as the previously described, biotin 
functionalized linker. Here, when the protein decorated structure is treated with a solution 
of biotin overnight, the higher molecular weight products that indicate the decoration of 
the tetrahedron with one or more protein disappears and a single, lower molecular weight 
product appears. This band corresponds well to the non-PS modified tetrahedron, 
representing that the proteins had been successfully removed from the structure with 
excellent yield.  
Future work (discussed in Chapter 4) will explore the selectivity of this 
competitive binding between streptavidin-desthiobiotin and streptavidin-biotin. 
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3.3 Conclusions 
 We have successfully demonstrated one of the most important claims of why 
phosphorothioate DNA modifications is an excellent candidate for the decoration of 
complex DNA nanostructures, mainly that it introduces minimal disruptions to the 
Watson-Crick base pairing and the ultimate stability of the DNA nanostructures. In this 
work, we have demonstrated the decoration of two different tetrahedron nanostructures 
using PS-modified DNA strands with multiple cargoes, demonstrated the orientation 
control over the cargo inside or outside of the tetrahedron, and finally, the release of the 
tetrahedron from the tetrahedron structure for possible applications for in vitro or in vivo 
therapeutic applications.  This technique has demonstrated wide applicability in DNA 
tiled assemblies in both two and three dimensions and should find further applications in 
decoration of more complex, tile based DNA structures. However, with the introduction 
of the DNA origami structures by Rothemund in 2006, one of the fundamental challenges 
in addressability within a DNA structure was solved. The origami method will be 
discussed in detail in Chapter 4. (27) 
3.4 Experimental Details 
Materials. Biotin polyethyleneoxide iodoacetate was purchased from Sigma-
Aldrich (B2059) and used as received. The PS modified central strand (10 µM) was 
incubated in 1x TAE-Mg2+ buffer with 4 mM of BPI at 50 °C for 5 hours. After 
incubation, excess salt and linker was removed by washing 15 times with millipore water  
using a 100 kDa Amicon. The conjugated DNA was analyzed by mass spec (MALDI-
TOF) to confirm successful conjugation. 
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DNA (He’s tetrahedron). DNA sequences were adapted from previous works, 
which were originally designed by a computer program “SEQUIN” (Seeman, N. C. J. 
Biomol. Struct. Dyn. 1990, 8, 573-581). All oligonucleotides were HPLC purified and 
purchased from IDT, Inc (Coralville, IA). Long strand: AGG CAC CAT CGT AGG TTT 
TTC TTG CCA GGC ACC ATC GTA GGT T*T*T* TCT TGC CAG GCA CCA TCG 
TAG GTT TTT CTT GCC ; medium strand: TAG CAA CCT GCC TGG CAA GCC 
TAC GAT GGA CAC GGT AAC GCC; short peripheral strand: TTA CCG TGT GGT 
TGC TAG GCG. *denotes a phosphorothioate bond. 
DNA (Goodman’s tetrahedron). Side 1: AGG CAG TTG AGA CGA ACA TTC 
CTA AGT CTG AAA TTT ATC ACC CGC CAT AGT AGA CGT ATC ACC; Side 2 – 
CTT GCT ACA CGA TTC AGA CTT AGG AAT GTT CGA CAT GCG AGG GTC 
CAA TAC CGA CGA TTA CAG; Side 3 – GGT GAT AAA ACG TGT AGC AAG 
CTG TAA TCG ACG GGA AGA GCA TGC CCA TCC ACT ACT ATG GCG; Side 4 – 
CCT CGC ATG ACT CAA CTG CCT GGT GAT ACG AGG ATG GGC ATG CTC 
TTC CCG ACG GTA TTG GAC. 
As synthesized central PS-DNA strand from IDT has a calculated mass of 
23956.6 g/mole and a measured mass of 23957.7 g/mole. Biotin polyethyleneoxide 
iodoacetate has a mass of 542.43 g/mole and the product of the reaction has a predicted 
mass of 24373, 24788, and 25204 g/mole for PS-DNA conjugated with 1, 2, and 3 linkers, 
respectively. Mass spectroscopy confirms successful conjugation of biotin 
polyethyleneoxide iodoacetate linker to PS-DNA with major peaks at 24350, 24813, and 
25211 g/mol. PS-DNA mass spec supplied by IDT, biotinylated DNA analysis performed 
at UIUC Mass Spec Lab on a Voyager-DE STR (Applied Biosystems). 
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Desthiobiotin modification. The concentration of DNA was calculated based on 
absorption at 280 nm according to the Beer-Lambert law. and adjusted to 100 µM. A 10 
µM solution of 5` thiol modified DNA (used as received from IDT) was incubated with 2 
µL of tributylphosphine solution for 2 hours at room temperature to the reduce the 
disulfide bond. Next, a 35 mM solution of desthiobiotin polyethyleneoxide 
iodoacetamide was freshly prepared in a 1 x TAE-Mg2+ buffer (Tris, 40 mM; acetic acid, 
20 mM; EDTA, 2 mM; and magnesium acetate, 12.5 mM; pH 8.0) and incubated for 5 
hours at 50 °C. Excess linkers were removed by washing 10 times with water using a 30 
MWCO Amicon centrifugal filter. To purify the desthiobiotin functionalized product, the 
washed and concentrated solution was incubated with avidin agarose beads and eluted 
following manufacturers suggested protocols.  
Affinity Purification of Biotinylated PS-DNA. Biotin functionalized PS-DNA was 
purified from unmodified sequences using an avidin-agarose affinity column (Sigma-
Aldrich, A9207). Briefly, after conjugation of biotin polyethyleneoxide iodoacetate to 
PS-DNA following above procedure, the product was washed 15 times with Millipore 
water using a 100 kDa Amicon to remove excess salt and unconjugated linkers. The 
desalted product was diluted in 1 mL of 1x PBS buffer (binding buffer, 50 mM NaCl, pH 
7.2) then incubated with 1mL of avidin-agarose matrix for 2 hours at 25 °C. The matrix 
was washed with 15 mL of binding buffer to remove unmodified DNA. After washing, 
the matrix was incubated in 1.5 mL of 10 mM EDTA adjusted to pH 8.2 for 10 minutes at 
90 °C and immediate eluted to recover biotinylated PS-DNA strands. The eluted product 
was washed 10x with DI water with a 100 kDa Amicon to remove excess EDTA and 
adjusted to 3.3 µM as determined by UV absorbance at 260 nm.  
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PAGE Purification. Biotinylated tetrahedrons with 1 conjugated protein were 
purified by 4% native PAGE. The band corresponding to tetrahedron + 1 STV was cut, 
recovered, and eluted at 4 °C in 0.5x TAE-Mg2+ buffer for 12 hours, changing buffer at 4 
hour intervals. Finally, the recovered structures were concentrated before imaging. 
Aggregation found during imaging likely due to streptavidin crosslinking during and after 
purification process. 
AFM imaging. A 3 µL drop of DNA solution was spotted onto freshly cleaved 
mica surface, and kept for 10 s to achieve strong adsorption. The sample drop was then 
washed with 30 mM magnesium acetate solution, and dried by nitrogen. DNA samples 
were imaged in AC mode on an Asylum Cypher AFM in air using oxide-sharpened 
silicon probes having a resonance frequency in the range of 280–320 kHz (MikroMasch–
NSC15).  Fluid imaging was performed using nitride probes having a resonance 
frequency of 21-52 kHz (Olympus -TR400PSA). The tip–surface interaction was 
minimized by optimizing the scan set-point to the highest possible value. AFM imaging 
was performed at 22 °C. AFM data was processed with IGOR Pro software. 
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3.6  Figures 
 
 
 
 
Figure 3.1 Polyacrylamide gel shift assay. (Left band) Purified DNA-linker conjugate 
and (right lane) DNA-linker conjugate with streptavidin.  
 
 
 
 
 
Figure 3.2 Polyacrylamide gel titration assay to optimize volume ratios between strands. 
The rightmost band shows a phosphorothioate modified 3-arm motif intermediate 
decorated with a streptavidin protein.  
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Figure 3.3 (A) Chemical structure of a phosphorothioated DNA backbone and its 
subsequent covalent conjugation with the biotin polyethyleneoxide iodoacetamide 
bifunctional linker. (B) 3D schematic of formed tetrahedron structure with PS bonds 
represented in orange before and after conjugation. 
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Figure 3.4 Complete gel shift assay characterizing pre-purified PS/Linker modified DNA 
(lane 1), 3 arm motif intermediates (lane 2), unmodified tetrahedron structures (lane 3), 
reaction between streptavidin and un-modified tetrahedrons (lane 4), PS/Linker modified 
tetrahedrons (lane 5), and streptavidin decoration of PS/Linker modified tetrahedrons 
(lane 6). In lane 6, 4 high molecular weight bands can be observed, corresponding to 
tetrahedrons with 0, 1, 2, and 3 proteins attached. Notably absent is the 5th band that 
would correspond to a tetrahedron with 4 proteins conjugated.  
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Figure 3.5 Gel shift assay showing the completed, purified PS-tetrahedron before and 
after streptavidin (STV) incubation (lane 1 and 2) and the biotin functionalized 
tetrahedron before and after streptavidin incubation (lane 3 and 4). In lane 4, 5 bands are 
observable, corresponding to a DNA tetrahedron with 0, 1, 2, 3, and 4 protein conjugated 
to the vertexes.  
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Figure 3.6 AFM and cross section of DNA tetrahedron A) before and B) after incubation 
with streptavidin. The nanostructures without protein are well dispersed with average 
height of ~2 nm. After incubation, nanostructure size increases by ~4 nm to ~6 nm, 
indicating successful protein(s) conjugation, in good agreement with a measured protein 
size of ~4.5 nm. Scale bar represents 100 nm.  
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Figure 3.7 Fluid AFM imaging reveals some larger 2D structures adsorbed onto the mica. 
These structures have formed 2D hexagonal array based on the 3 point star motif and due 
to the biotin functionalization at the vertices, we can clearly see the streptavidin 
preferably binding to the array at the vertices. Smaller tetrahedrons likely do not bind 
well to the surface in liquid and cannot be imaged reproducibly. Scale bar represents 100 
nm.  
 
 
 
 
Figure 3.8 Stability comparison between unmodified and PS/Linker modified 
tetrahedrons stored at room temperature for 3 days. (Left) unmodified, (middle) PS-
modified, and (right) biotin-linker modified.  
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Figure 3.9 Gel shift assay characterizing Goodman’s tetrahedron, consisting of 4 DNA 
strands that each form half of one side of the tetrahedron (Lane 1). Phosphorothioate 
modifications were placed at the vertices and along the side of the tetrahedron on one of 
the sides (Lane 2). By taking accounting for the rotation of the double helix, it is possible 
to position the linker modification outward or inside the tetrahedron. If the modification 
is placed facing inward, the overall tetrahedron-protein conjugate is smaller (lane 3). If 
the modification is placed facing outward, the overall tetrahedron-protein conjugate is 
larger (lane 4). 
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Figure 3.10 Gel shift assay demonstrating that by using a linker incorporating a biotin-
analogue, it is possible to attach (left lane) and remove streptavidin proteins from the 
tetrahedron structure (right lane). This mechanism is further discussed in Chapter 4 of 
this thesis.  
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CHAPTER 4 
DYNAMIC CONJUGATION OF CARGO TO DNA ORIGAMI TILES – 
NANO-MORSE CODE AND DELIVERY APPLICATIONS 
Significant portions of this chapter were prepared as “Nano-Encryted Morse Code: A 
Versatile Approach to Programmable and Reversible Nanoscale Assembly and 
Disassembly” Ngo Yin Wong, Hang Xing, Li Huey Tan, and Yi Lu, Journal of the 
American Chemical Society 2012 submitted. 
4.1  Introduction 
This chapter continues the discussion of self-assembly of nanoscale objects on a 
DNA template. In this chapter, we discuss and explore one of latest advances in DNA 
based nanostructures, DNA origami, and its applications for addressable assembly with 
nanoscale precision. As was mentioned in Chapter 2 of this thesis, there are two main 
strategies toward the assembly of DNA nanostructures, tile based and origami. The main 
advantages of tile based assembly is the ability to generate large, two and three 
dimensional crystals based on rigid tiles with sticky ends. Tile based assembly, however, 
suffer from a number of inefficiencies that have limited their use in the broader scientific 
community. Mainly, the multi-armed tiles described by Seeman and coworkers do not 
allow a great deal of design freedom, requires careful radiometric titration to obtain high 
quality structures, and requires a long annealing process (24 to 48 hours). In 2006, Paul 
Rothemund was the first to describe the complete idea of DNA origami. While the 
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principles behind DNA origami have been proposed previously by others (1), the 
demonstration of its full potential remained unrealized. Rothemund, demonstrated for the 
first time, that by using a long naturally single stranded DNA (m13mp18, 7.8k base pairs) 
extracted from bacteria, hundreds of unique helper / staple sequences (usually 30 – 40 
base pairs) would hybridize and fold a particular section of the long single strand. 
Repeated hundreds of times, a particular set of stable strands will direct the folding of the 
long strand into a predetermined, arbitrary, and discreet shape. In his original publication, 
Rothemund demonstrated this by designing and assembling a series of shapes such as a 
star, rectangle, and squares to more intricate shapes such as a map of the world and a 
smilie face. The origami technique jumpstarted the DNA structural community and over 
the next several years, we saw the rise of three distinct classes of publications based on 
the DNA origami technique: origami tiles as a template for nanomaterials, extended two 
and three dimensional structures, and active nano-mechanical devices.  
One of the most difficult and least explored areas of DNA nanostructures remains 
the design and assembly of discreet, three dimensional structures. Anderson et al. (2) 
demonstrated one of the earliest 3D structures in the form of a 42 nm x 36 nm x 36 nm 
box with a controllable lid, which can be opened using a DNA ‘key.’ Shih, Yan, and 
colleagues next developed a more general strategy toward 3D structures (3) by 
systematically folding pleated layers of helices constrained into honeycomb (4), square 
(5), and hexagonal lattices (6). Dongran and coworkers (7) demonstrated the versatility of 
this approach by designing and assembling a 100 nm Mobius strip, supercoiled rings, and 
catenane structures through a fold-and-cut strategy. However, the assembly of these 
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exotic and complex structures suffered from yields of only ~ 20%, rendering them more a 
research wonder than a practical tool for further studies. In a surprising study, Jean-
Philippe and coworkers (8) found that nothing happens throughout most of the annealing 
/ assembly process, but rather, at a critical temperature, the origami tiles forms very 
rapidly and if the temperature is held at this critical temperature, even highly complex 
three dimensional structures can form will yields close to 100% within an hour. In this 
chapter, we will also present our data on the mechanistic studies of 2D origami tiles. 
Very recently, Wei et al. (9) published a follow-up to the origami technique that is 
expected to generate new excitement in the field. One of the limiting steps in 
Rothemund’s origami method is the single stranded bacteriophage DNA that cannot be 
obtained artificially and accounts of a considerable portion of the costs. By designing and 
using single stranded tiles (SST), Wei et al. circumvented this shortfall by using 
hundreds, and up to thousands of short single strands that act as tiles by associating with 
up to 4 other strands to form the desired shape.  
In order for assembled DNA nanostructures to be applicable in directed self-
assembly of nanomaterials, a conjugation method between the nanomaterial and the DNA 
scaffold is needed. The reader is directed to an excellent review by Sacca and Niemeyer 
(10) for an in-depth review of recent advances in DNA-protein hybrids. Some of the 
highlighted chemistries include nitrilotriacetic acid (NTA), aptamers, alkylthiol-amine 
and alkylthiol-thiol chemistries. Unsurprisingly for people familiar with the field, one of 
the most commonly used conjugation technique is the (strept)avidin-biotin complex. With 
a disassociate constant of roughly 10-15 M, it ranks among one of the strongest non-
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covalent bond found in nature and is mostly a result of hydrophobic interactions and 
hydrogen bonding. With a staggeringly high affinity for binding, mild conjugation 
conditions, and widely available commercial products, the biotin-streptavidin conjugation 
is the often the proof of concept chemistry for nanoscale assemblies to achieve high 
yields. However, one of the drawbacks of this reaction is that due to the strong binding, 
removing the protein from biotin requires a combination of high temperature, extreme 
pH, and other chaotropic elements are required to disrupt it. Since these disruptive forces 
often destabilize or even destroy the materials on which the conjugation pair reside (e.g., 
double stranded DNA, proteins, nanoparticles) such a reaction is incompatible for many 
systems for which dynamic and reversible assembly and disassembly are of interest.  
Programmable assembly of functional materials at the nanometer scale with 
designed patterns has received increasing attention in scientific research and engineering, 
because of its potential applications in electronics, photonics, and medicine. An excellent 
example of recent success in programmable assembly of nanomaterials was the 
development of structural DNA (11) and DNA origami (12,13) as a template for 
assembly of functional components such as nanoparticles (14-17), quantum dots (18,19), 
carbon nanotubes (20), and proteins (21-24). More recent advances in design (3,25), large 
scale patterning (26), and assembly of DNA origami structures in 1D (27), 2D (28,29) 
and 3D (2,30) offer a path towards practical applications. While tremendous progress has 
been made in the assembly of these components with excellent spatial resolution, a 
significant gap remains in our ability to achieve selectively reversible assembly of certain 
component(s) at selective site(s); exerting such a control of the assembly process will 
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make it possible to fine-tune the functional properties of the assembly and to realize more 
complex designs by replacing one component of the assembly with another in subsequent 
assembly steps.  
Reversible processes are common in biology as well as in large-scale engineering 
systems, serving many important functions.  For example, the reversible process in 
protein synthesis makes it possible to proof-read and correct errors in incorporation of 
wrong amino acids with a similar structure.  Despite many such examples of 
programmable, reversible control of the processes both in biology and in bulk-scale 
engineering systems, very few processes in nanoscale assembly demonstrate similar 
controllability. (31-34) One successful strategy to achieve selective, reversible nanoscale 
binding is through the use of complementary DNA, invasive DNA strands, or toe-hold 
DNA designs. These techniques have been widely applied for use in DNA walkers and 
DNA motors that follow preprogrammed paths. (35-38) While the technique is useful, the 
use of DNA hybridization-based conjugation is limited to buffered conditions similar to 
that found in the cellular environment. In contrast, covalent conjugation techniques form 
stable linkages but typically suffer from lower yields and require specific reaction 
conditions. Consequently there are few examples of completely reversible bonding under 
mild conditions. 
An early motivation for the current work lies with a key semiconductor 
processing technique: lift-off. One of the most important concepts in complex top-down 
lithography, a pattern is defined on a surface via a polymer (usually a photoresist). The 
polymer is then selectively cross-linked and the un-crosslink sections are washed away 
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and a material is deposited. Afterwards, the cross-linked section is removed and the same 
process is repeated to generate a new pattern of a new material. The idea is that the same 
process can be repeated to generate increasingly complex patterns with multiple different 
materials. By using the same patterning technique (masking and lift-off) the overall 
complexity of the process is reduced. The goal of this project was to extend this process 
into the nanoscale by using a reversible chemistry to effective “mask” an area of a 
template, which can later be removed and be available of subsequent modifications, using 
the same chemistry. This process enables the ability to achieve dynamic assemblies that 
are responsive to their environment, and if we can adopt a widely used chemistry for this 
purpose, the applications can be wide reaching. Today, one of the main strategies toward 
responsive assemblies or “robots” has been the use of competitive DNA hybridization. 
The idea is simple; a strand hybridized to a second strand can be displaced by a third 
strand if there are more complementary base pairs between the two strands. This process 
can be encouraged further with the introduction of toe-holds, protruding single stranded 
regions by lowering the activation energy for the competitive binding by giving the 
invading strand a favorable site to initiate hybridization. This technique has been 
extensively explored by researchers interested in molecular robots. (35) While DNA 
satisfies many of the requirements for basic research, it remains a niche research curiosity 
for the wider research community. One reason is likely the relatively low thermal stability 
and the need for buffered conditions to maintain the double-stranded helix of DNA.  
On the other hand, the biotin-(strept)avidin conjugation pair is widely used in 
nanoscale science and technology today, thanks to the conjugation’s exceptional stability 
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and selectivity while requiring only mild conditions. As a result; it is commonly used to 
functionalize nanomaterials such as metal nanoparticles, quantum dots, carbon nanotubes, 
and proteins, as well as on a variety of surfaces, many of which are available 
commercially. A significant shortcoming of this conjugation, however, is its near 
irreversibility. Due to the extraordinarily strong binding affinity of the interaction (Kd ~ 
10-15 M), Desthiobiotin, with a binding affinity to streptavidin ~1000 times weaker than 
biotin (Kd ~ 10-11 M), has long been used with solid supports to purify biotin-binding 
proteins under mild conditions by competition with free biotin in solution, but to our 
knowledge has not yet been exploited for nanoscale assembly.  To demonstrate its utility 
in selective and reversible assembly, we first compared the binding of biotinylated and 
desthiobiotinylated DNA strands with streptavidin.   
4.2 Results and Discussion 
Desthiobiotin, with a binding affinity to streptavidin ~1000 times weaker than 
biotin, has long been used with solid supports to purify biotin-binding proteins under 
mild conditions and released through competition with free biotin in solution, (39,40) but 
to our knowledge has not yet been exploited for nanoscale assembly.  To demonstrate its 
utility in selective and reversible assembly, we first compared the binding of biotinylated 
and desthiobiotinylated DNA strands with streptavidin.  To introduce desthiobiotin onto 
the DNA, an oligonucleotide bearing a dithiol on the 5` end was first incubated with 5 
mM tributylphosphine in 1x TAE-Mg2+ to reduce disulfide bonds to expose a reactive 
thiol moiety at the 5` end. The resulting HS-DNA was then reacted with desthiobiotin 
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polyethyleneoxide iodoacetamide for 5 hours at 20 °C. After purification by 100k 
MWCO Amicon, mass spectrometry was used to confirm that 90% of DNA strands were 
successfully conjugated with desthiobiotin (see supplemental information). To achieve 
100% purity, the above mixture was purified via an avidin agarose affinity column 
following manufacturer’s instructions. The final product was confirmed by a gel shift 
assay. It is noted that desthiobiotinylated oligonueoclides are now available commercially 
through Integrated DNA technology.  
To illustrate the binding activity and release of streptavidin from the 
functionalized DNA, either biotinylated or desthiobiotinylated DNA strands were 
incubated with 1 µM streptavidin for 2 hours at room temperature, the mixtures were then 
treated with 5 mM biotin in 1x TAE buffer overnight and analyzed by a gel shift assay. As 
shown in Figure 1B, upon incubation with streptavidin, both biotinylated and 
desthiobiotinylated DNA strands in Lanes 1 and 2 transformed into discrete, higher 
molecular weight products (see Lanes 3 and 4), indicating specific conjugation of the 
streptavidin with both DNA strands. In contrast, subsequent treatment of both conjugates 
with excess biotin at room temperature resulted in a different migration of the bands on 
the gel; while addition of excess biotin did not change the position of the biotinylated 
DNA strand, the addition under the same condition resulted in a complete reversal of the 
conjugated high molecular band to the lower molecular weight of free 
desthiobiontinylated DNA. These results reveal the competitive binding mechanism 
whereby biotin specifically replaces the weaker binding desthiobiotin from streptavidin, 
effectively reversing the conjugation process. The process was repeated by recovering the 
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free desthiobiotinylated DNA strand and again incubating with free streptavidin, 
confirming that the binding is fully reversible and that no observable degradation of 
desthiobiotin occurred during the process (Figure 5.2). 
Having demonstrated full reversibility of the desthiobiotinylated DNA system, we 
then explored its application in reversible nanoscale assemblies on a rectangular 100 x 70 
nm2 DNA origami tile prepared by folding the single-stranded 7,249 base DNA genome 
of the bacteriophage M13mp18 in the presence of 226 shorter “staple” strands. (12) 
Because each of the 226 strands is uniquely indexed on the tile, site-specific modification 
on the DNA origami tile is a simple process of picking and functionalizing the desired 
strands based on a diagram of the staple strands. The resulting patterns on each tile can be 
revealed by incubating the tiles with streptavidin and then obtaining the images under 
atomic force microscope.   
As a first demonstration of this methodology, we investigated the application of 
this methodology towards the encryption of a message written in Morse code at the 
nanoscale. Invented in the 1840’s, Morse code was the prevalent language of 
telecommunication for most of the 19th and into the 20th century. Consisting of a series of 
dots and dashes that make up the alphabet, we constructed a message using proteins 
while simultaneously “encrypting” the message with excess proteins (Figure 5.3). To 
design the nano-Morse codes, a “primary” pattern or masked message is first defined by 
selecting a series of staple strands that gives the best representation of the original design. 
Within this pattern of sequences, it is then possible to incorporate a “secondary” design, 
or hidden message or code. The secondary design consists of sequences that are modified 
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with biotin while the remaining staple strands of the primary design are functionalized 
with desthiobiotin. As a result, the primary design will be visible after streptavidin 
incubation and the secondary design or decoded message will be revealed after 
incubation in an excess solution of biotin. 
To realize the encrypted Morse code, we designed an origami tile consisting of 9 
desthiobiotinylated and 15 biotinylated staple strands to encode the word “NANO.” In 
the current design, each row represents one letter, with 2 proteins representing a dash and 
a single protein corresponding to a dot within Morse code. Translated, the encrypted 
message generated simply by incubating the tile with streptavidin represents a 
nonsensical encrypted message. However, upon subsequent addition of the biotin 
“decoder,” the original intended message “NANO” can be revealed (Figure 5.4).  
Based on the above design, a combination of biotin and desthiobiotin modified 
staple strands representing specific positions within the origami scaffold, the modified 
staple strands, along with unmodified strands were annealed from 90 °C to 20 °C over 5 
hours to form the desired origami structure. After the formed DNA tiles were filtered by 
100k MWCO Amicon membranes to remove excess staple strands, the formed tiles were 
allowed to incubate with a 20 times excess of streptavidin overnight in 1x TAE-Mg2+. 
Subsequent high resolution AFM reveals a 4x3 array of dashes (each consisting of 2 
proteins) (Figure 2D), as predicted in our scheme. The measured height of the DNA tile 
and protein are 1.7 nm and 4 nm respectively, in excellent agreement with the known 
dimensions of these biomolecules.  
Next, to demonstrate selective release of protein from origami template and thus 
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revealing of the nanoscale Morse code, the protein-decorated tiles were treated with 
biotin for 2 hours at room temperature. The AFM images in Figure 5.4 show that the 
addition of biotin was able to reveal the hidden Morse code message “NANO.”  
AFM analysis of 8 well-formed, encrypted nano-Morse code tiles similar to those 
shown in Figure 2D reveal that 90% of the streptavidin had bound correctly (Figure 5.6). 
Interestingly, the percentage of the streptavidin bound correctly to biotin-modified staple 
strands was ~95% while the same tiles only had ~84% bound correctly to 
desthiobiotinylated modified strands. This discrepancy is likely due to the weaker binding 
affinity of desthiobiotin to streptavidin than biotin. Furthermore, even with minimal 
tapping force between the AFM probe and the sample, it is conceivable that some 
proteins were removed through tip interactions. Because of the differences in affinity for 
streptavidin, more desthiobiotin-bound streptavidin would be dislodged then the biotin-
bound proteins. Following incubation with biotin solution to displace desthiobiotin-bound 
streptavidin, an analysis of 8 well-formed tiles similar to that shown in Figure 5.7 shows 
that approximately 96% of the proteins are correctly bound, confirming reversible 
assembly in high yield. 
To further demonstrate the versatility and reversibility of the method described 
here, we designed an “I” pattern made of a combination of biotin and desthiobiotin 
modifications (Figure 5.5). The second design is inspired by the University of Illinois 
logo of a capital I. Upon addition of biotin, the lower case “i” can then be revealed. 
Furthermore, addition of streptavidin can restore display of the original capital letter. 
More importantly, due to the small separation between biotin and desthiobiotin 
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modifications, we were able to investigate whether the spacing between conjugated 
streptavidin would hinder the binding or release of the protein from desthiobiotin in the 
presence of excess biotin. Following similar procedures as before, we observed under 
AFM highly efficient formation of DNA origami rectangles with a clear capital “I” after 
initial incubation with streptavidin. Following overnight incubation with biotin at 4º C, 
more than 90% of the tiles were successfully converted to a lower case “i” pattern, 
demonstrating efficient and selective removal of proteins attached to desthiobiotin. To 
demonstrate the availability of desthiobiotin sites for subsequent functionalization, the 
system was again incubated with excess streptavidin. AFM imaging (Figure 5.5) shows 
greater than 70% of the desthiobiotin sites available on the tiles were bound to 
streptavidin, demonstrating the reversible nature of the conjugation.  
In order for DNA origami to become an established technique in template directed 
self-assembly of nanomaterials, there is a need to gain mechanical insights into the 
formation of such a densely packed DNA structure.    
4.3 Conclusions 
In conclusion, we take advantage of the different binding affinities of biotin and 
desthiobiotin toward streptavidin and demonstrate for the first time selective and 
reversible deco-ration of DNA origami tiles with streptavidin. In the first demonstration 
of such a versatile approach, we showed that an encrypted Morse code message could be 
revealed after addition of biotin to replace desthiobiotin-bound streptavi-din. In a further 
demonstration of reversibility, a pattern of letter “I” can be replaced with “i” first, and 
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then restored back to “I”. The yields of the conjugations are high (> 90%) and the process 
is reversible. The technique presented here should find wide applications within the fields 
of nano-eletronics, photonics, and biomedicine where it is desirable for researchers to 
create nanoscale assemblies with pro-grammable capture and release of multiple 
nanomaterials. 
4.4  Experimental Details 
Chemicals and Materials. All Oligonucleotides used in the current study were 
purchased from Integrated DNA Technologies (Coralville, IA). M13 viral DNA was 
purchased from New England Biolabs, Inc. (#N4040S, NEB). Tributylphosphine solution 
(200 mM, in N-methyl-2-pyrrolidinone; Sigma-Aldrich), Desthiobiotin 
polyethyleneoxide Iodoacetamide (>90%, Sigma-Aldrich), Avidin agarose (6% beaded 
agarose, Thermo Scientific) Amicon centrifugal filter units (100,000 MWCO, Millipore). 
All buffer components were purchased from Sigma Aldrich unless otherwise noted. 
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Origami Design and Sequences. 
 
Table 4.1 Staple strands for 100 x 70 nm rectangular origami structure. 
Sequence 
Name Sequence 
1 CAAGCCCAATAGGAAC CCATGTACAAACAGTT 
2 AATGCCCCGTAACAGT GCCCGTATCTCCCTCA 
3 TGCCTTGACTGCCTAT TTCGGAACAGGGATAG 
4 GAGCCGCCCCACCACC GGAACCGCGACGGAAA 
5 AACCAGAGACCCTCAG AACCGCCAGGGGTCAG 
6 TTATTCATAGGGAAGG TAAATATT CATTCAGT 
7 CATAACCCGAGGCATA GTAAGAGC TTTTTAAG 
8 ATTGAGGGTAAAGGTG AATTATCAATCACCGG 
9 AAAAGTAATATCTTAC CGAAGCCCTTCCAGAG 
10 GCAATAGCGCAGATAG CCGAACAATTCAACCG 
11 CCTAATTTACGCTAAC GAGCGTCTAATCAATA 
12 TCTTACCAGCCAGTTA CAAAATAAATGAAATA 
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Table 4.1 (Continued) 
13 ATCGGCTGCGAGCATG TAGAAACCTATCATAT 
14 CTAATTTATCTTTCCT TATCATTCATCCTGAA 
15 GCGTTATAGAAAAAGC CTGTTTAGAAGGCCGG 
16 GCTCATTTTCGCATTA AATTTTTGAGCTTAGA 
17 AATTACTACAAATTCT TACCAGTAATCCCATC 
18 TTAAGACGTTGAAAAC ATAGCGATAACAGTAC 
19 TAGAATCCCTGAGAAG AGTCAATAGGAATCAT 
20 CTTTTACACAGATGAA TATACAGTAAACAATT 
21 TTTAACGTTCGGGAGA AACAATAATTTTCCCT 
22 CGACAACTAAGTATTA GACTTTACAATACCGA 
23 GGATTTAGCGTATTAA ATCCTTTGTTTTCAGG 
24 ACGAACCAAAACATCG CCATTAAATGGTGGTT 
25 GAACGTGGCGAGAAAG GAAGGGAACAAACTAT 
26 TAGCCCTACCAGCAGA AGATAAAAACATTTGA 
27 CGGCCTTGCTGGTAAT ATCCAGAACGAACTGA 
28 CTCAGAGCCACCACCC TCATTTTCCTATTATT 
29 CTGAAACAGGTAATAA GTTTTAACCCCTCAGA 
30 AGTGTACTTGAAAGTA TTAAGAGGCCGCCACC 
31 GCCACCACTCTTTTCA TAATCAAACCGTCACC 
32 GTTTGCCACCTCAGAG CCGCCACCGATACAGG 
33 GACTTGAGAGACAAAA GGGCGACAAGTTACCA 
34 AGCGCCAACCATTTGG GAATTAGATTATTAGC 
35 GAAGGAAAATAAGAGC AAGAAACAACAGCCAT 
36 GCCCAATACCGAGGAA ACGCAATAGGTTTACC 
37 ATTATTTAACCCAGCT ACAATTTTCAAGAACG 
38 TATTTTGCTCCCAATC CAAATAAGTGAGTTAA 
39 GGTATTAAGAACAAGA AAAATAATTAAAGCCA 
40 TAAGTCCTACCAAGTA CCGCACTCTTAGTTGC 
41 ACGCTCAAAATAAGAA TAAACACCGTGAATTT 
42 AGGCGTTACAGTAGGG CTTAATTGACAATAGA 
43 ATCAAAATCGTCGCTA TTAATTAACGGATTCG 
44 CTGTAAATCATAGGTC TGAGAGACGATAAATA 
45 CCTGATTGAAAGAAAT TGCGTAGACCCGAACG 
46 ACAGAAATCTTTGAAT ACCAAGTTCCTTGCTT 
47 TTATTAATGCCGTCAA TAGATAATCAGAGGTG 
  
101 
 
 
Table 4.1 (Continued) 
48 AGATTAGATTTAAAAG TTTGAGTACACGTAAA 
49 AGGCGGTCATTAGTCT TTAATGCGCAATATTA 
50 GAATGGCTAGTATTAA CACCGCCTCAACTAAT 
51 CCGCCAGCCATTGCAA CAGGAAAAATATTTTT 
52 CCCTCAGAACCGCCAC CCTCAGAACTGAGACT 
53 CCTCAAGAATACATGG CTTTTGATAGAACCAC 
54 TAAGCGTCGAAGGATT AGGATTAGTACCGCCA 
55 CACCAGAGTTCGGTCA TAGCCCCCGCCAGCAA 
56 TCGGCATTCCGCCGCC AGCATTGACGTTCCAG 
57 AATCACCAAATAGAAA ATTCATATATAACGGA 
58 TCACAATCGTAGCACC ATTACCATCGTTTTCA 
59 ATACCCAAGATAACCC ACAAGAATAAACGATT 
60 ATCAGAGAAAGAACTG GCATGATTTTATTTTG 
61 TTTTGTTTAAGCCTTA AATCAAGAATCGAGAA 
62 AGGTTTTGAACGTCAA AAATGAAAGCGCTAAT 
63 CAAGCAAGACGCGCCT GTTTATCAAGAATCGC 
64 AATGCAGACCGTTTTT ATTTTCATCTTGCGGG 
65 CATATTTAGAAATACC GACCGTGTTACCTTTT 
66 AATGGTTTACAACGCC AACATGTAGTTCAGCT 
67 TAACCTCCATATGTGA GTGAATAAACAAAATC 
68 AAATCAATGGCTTAGG TTGGGTTACTAAATTT 
69 GCGCAGAGATATCAAA ATTATTTGACATTATC 
70 AACCTACCGCGAATTA TTCATTTCCAGTACAT 
71 ATTTTGCGTCTTTAGG AGCACTAAGCAACAGT 
72 CTAAAATAGAACAAAG AAACCACCAGGGTTAG 
73 GCCACGCTATACGTGG CACAGACAACGCTCAT 
74 GCGTAAGAGAGAGCCA GCAGCAAAAAGGTTAT 
75 GGAAATACCTACATTT TGACGCTCACCTGAAA 
76 TATCACCGTACTCAGG AGGTTTAGCGGGGTTT 
77 TGCTCAGTCAGTCTCT GAATTTACCAGGAGGT 
78 GGAAAGCGACCAGGCG GATAAGTGAATAGGTG 
79 TGAGGCAGGCGTCAGA CTGTAGCGTAGCAAGG 
80 TGCCTTTAGTCAGACG ATTGGCCTGCCAGAAT 
81 CCGGAAACACACCACG GAATAAGTAAGACTCC 
82 ACGCAAAGGTCACCAA TGAAACCAATCAAGTT 
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Table 4.1 (Continued) 
83 TTATTACGGTCAGAGG GTAATTGAATAGCAGC 
84 TGAACAAACAGTATGT TAGCAAACTAAAAGAA 
85 CTTTACAGTTAGCGAA CCTCCCGACGTAGGAA 
86 GAGGCGTTAGAGAATA ACATAAAAGAACACCC 
87 TCATTACCCGACAATA AACAACATATTTAGGC 
88 CCAGACGAGCGCCCAA TAGCAAGCAAGAACGC 
89 AGAGGCATAATTTCAT CTTCTGACTATAACTA 
90 TTTTAGTTTTTCGAGC CAGTAATAAATTCTGT 
91 TATGTAAACCTTTTTT AATGGAAAAATTACCT 
92 TTGAATTATGCTGATG CAAATCCACAAATATA 
93 GAGCAAAAACTTCTGA ATAATGGAAGAAGGAG 
94 TGGATTATGAAGATGA TGAAACAAAATTTCAT 
95 CGGAATTATTGAAAGG AATTGAGGTGAAAAAT 
96 ATCAACAGTCATCATA TTCCTGATTGATTGTT 
97 CTAAAGCAAGATAGAA CCCTTCTGAATCGTCT 
98 GCCAACAGTCACCTTG CTGAACCTGTTGGCAA 
99 GAAATGGATTATTTAC ATTGGCAGACATTCTG 
100 TTTT TATAAGTA TAGCCCGGCCGTCGAG 
101 AGGGTTGA TTTT ATAAATCC TCATTAAATGATATTC 
102 ACAAACAATTTTAATCAGTAGCGACAGATCGATAGC 
103 AGCACCGTTTTTTAAAGGTGCAACATAGTAGAAAA 
104 TACATACATTTTGACGGGAGAATTAACTACAGGGAA 
105 GCGCATTA TTTT GCTTATCC GGTATTCTAAATCAGA 
106 TATAGAAGTTTTCGACAAAAGGTAAAGTAGAGAATA 
107 TAAAGTACTTTTCGCGAGAA AACTTTTTATCGCAAG 
108 ACAAAGAA TTTT ATTAATTA CATTTAACACATCAAG 
109 AAAACAAA TTTT TTCATCAA TATAATCCTATCAGAT 
110 GATGGCAA TTTT AATCAATA TCTGGTCACAAATATC 
111 
AAACCCTCTTTTACCAGTAA TAAAAGGGATTCACCA 
GTCACACG TTTT 
112 CCGAAATCCGAAAATC CTGTTTGAAGCCGGAA 
113 CCAGCAGGGGCAAAAT CCCTTATAAAGCCGGC 
114 GCATAAAGTTCCACAC AACATACGAAGCGCCA 
115 GCTCACAATGTAAAGC CTGGGGTGGGTTTGCC 
116 TTCGCCATTGCCGGAA ACCAGGCATTAAATCA 
117 GCTTCTGGTCAGGCTG CGCAACTGTGTTATCC 
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Table 4.1 (Continued) 
118 GTTAAAATTTTAACCA ATAGGAACCCGGCACC 
119 AGACAGTCATTCAAAA GGGTGAGAAGCTATAT 
120 AGGTAAAGAAATCACC ATCAATATAATATTTT 
121 TTTCATTTGGTCAATA ACCTGTTTATATCGCG 
122 TCGCAAATGGGGCGCG AGCTGAAATAATGTGT 
123 TTTTAATTGCCCGAAA GACTTCAAAACACTAT 
124 AAGAGGAACGAGCTTC AAAGCGAAGATACATT 
125 GGAATTACTCGTTTAC CAGACGACAAAAGATT 
126 GAATAAGGACGTAACA AAGCTGCTCTAAAACA 
127 CCAAATCACTTGCCCT GACGAGAACGCCAAAA 
128 CTCATCTTGAGGCAAA AGAATACAGTGAATTT 
129 AAACGAAATGACCCCC AGCGATTATTCATTAC 
130 CTTAAACATCAGCTTG CTTTCGAGCGTAACAC 
131 TCGGTTTAGCTTGATA CCGATAGTCCAACCTA 
132 TGAGTTTCGTCACCAG TACAAACTTAATTGTA 
133 CCCCGATTTAGAGCTT GACGGGGAAATCAAAA 
134 GAATAGCCGCAAGCGG TCCACGCTCCTAATGA 
135 GAGTTGCACGAGATAG GGTTGAGTAAGGGAGC 
136 GTGAGCTAGTTTCCTG TGTGAAATTTGGGAAG 
137 TCATAGCTACTCACAT TAATTGCGCCCTGAGA 
138 GGCGATCGCACTCCAG CCAGCTTTGCCATCAA 
139 GAAGATCGGTGCGGGC CTCTTCGCAATCATGG 
140 AAATAATTTTAAATTG TAAACGTTGATATTCA 
141 GCAAATATCGCGTCTG GCCTTCCTGGCCTCAG 
142 ACCGTTCTAAATGCAA TGCCTGAGAGGTGGCA 
143 TATATTTTAGCTGATA AATTAATGTTGTATAA 
144 TCAATTCTTTTAGTTT GACCATTACCAGACCG 
145 CGAGTAGAACTAATAG TAGTAGCAAACCCTCA 
146 GAAGCAAAAAAGCGGA TTGCATCAGATAAAAA 
147 TCAGAAGCCTCCAACA GGTCAGGATCTGCGAA 
148 CCAAAATATAATGCAG ATACATAAACACCAGA 
149 CATTCAACGCGAGAGG CTTTTGCATATTATAG 
150 ACGAGTAGTGACAAGA ACCGGATATACCAAGC 
151 AGTAATCTTAAATTGG GCTTGAGAGAATACCA 
152 GCGAAACATGCCACTA CGAAGGCATGCGCCGA 
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Table 4.1 (Continued) 
153 ATACGTAAAAGTACAA CGGAGATTTCATCAAG 
154 CAATGACACTCCAAAA GGAGCCTTACAACGCC 
155 AAAAAAGGACAACCAT CGCCCACGCGGGTAAA 
156 TGTAGCATTCCACAGA CAGCCCTCATCTCCAA 
157 GTAAAGCACTAAATCG GAACCCTAGTTGTTCC 
158 AGTTTGGAGCCCTTCA CCGCCTGGTTGCGCTC 
159 AGCTGATTACAAGAGT CCACTATTGAGGTGCC 
160 ACTGCCCGCCGAGCTC GAATTCGTTATTACGC 
161 CCCGGGTACTTTCCAG TCGGGAAACGGGCAAC 
162 CAGCTGGCGGACGACG ACAGTATCGTAGCCAG 
163 GTTTGAGGGAAAGGGG GATGTGCTAGAGGATC 
164 CTTTCATCCCCAAAAA CAGGAAGACCGGAGAG 
165 AGAAAAGCAACATTAA ATGTGAGCATCTGCCA 
166 GGTAGCTAGGATAAAA ATTTTTAGTTAACATC 
167 CAACGCAATTTTTGAG AGATCTACTGATAATC 
168 CAATAAATACAGTTGA TTCCCAATTTAGAGAG 
169 TCCATATACATACAGG CAAGGCAACTTTATTT 
170 TACCTTTAAGGTCTTT ACCCTGACAAAGAAGT 
171 CAAAAATCATTGCTCC TTTTGATAAGTTTCAT 
172 TTTGCCAGATCAGTTG AGATTTAGTGGTTTAA 
173 AAAGATTCAGGGGGTA ATAGTAAACCATAAAT 
174 TTTCAACTATAGGCTG GCTGACCTTGTATCAT 
175 CCAGGCGCTTAATCAT TGTGAATTACAGGTAG 
176 CGCCTGATGGAAGTTT CCATTAAACATAACCG 
177 TTTCATGAAAATTGTG TCGAAATCTGTACAGA 
178 ATATATTCTTTTTTCA CGTTGAAAATAGTTAG 
179 AATAATAAGGTCGCTG AGGCTTGCAAAGACTT 
180 CGTAACGATCTAAAGT TTTGTCGTGAATTGCG 
181 ACCCAAATCAAGTTTT TTGGGGTCAAAGAACG 
182 TGGACTCCCTTTTCAC CAGTGAGACCTGTCGT 
183 TGGTTTTTAACGTCAA AGGGCGAAGAACCATC 
184 GCCAGCTGCCTGCAGG TCGACTCTGCAAGGCG 
185 CTTGCATGCATTAATG AATCGGCCCGCCAGGG 
186 ATTAAGTTCGCATCGT AACCGTGCGAGTAACA 
187 TAGATGGGGGGTAACG CCAGGGTTGTGCCAAG 
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Table 4.1 (Continued) 
188 ACCCGTCGTCATATGT ACCCCGGTAAAGGCTA 
189 CATGTCAAGATTCTCC GTGGGAACCGTTGGTG 
190 TCAGGTCACTTTTGCG GGAGAAGCAGAATTAG 
191 CTGTAATATTGCCTGA GAGTCTGGAAAACTAG 
192 CAAAATTAAAGTACGG TGTCTGGAAGAGGTCA 
193 TGCAACTAAGCAATAA AGCCTCAGTTATGACC 
194 TTTTTGCGCAGAAAAC GAGAATGAATGTTTAG 
195 AAACAGTTGATGGCTT AGAGCTTATTTAAATA 
196 ACTGGATAACGGAACA ACATTATTACCTTATG 
197 ACGAACTAGCGTCCAA TACTGCGGAATGCTTT 
198 CGATTTTAGAGGACAG ATGAACGGCGCGACCT 
199 CTTTGAAAAGAACTGG CTCATTATTTAATAAA 
200 GCTCCATGAGAGGCTT TGAGGACTAGGGAGTT 
201 ACGGCTACTTACTTAG CCGGAACGCTGACCAA 
202 AAAGGCCGAAAGGAAC AACTAAAGCTTTCCAG 
203 GAGAATAGCTTTTGCG GGATCGTCGGGTAGCA 
204 ACGTTAGTAAATGAAT TTTCTGTAAGCGGAGT 
205 TTTT CGATGGCC CACTACGTAAACCGTC 
206 TATCAGGGTTTTCGGTTTGC GTATTGGGAACGCGCG 
207 GGGAGAGGTTTTTGTAAAACGACGGCCATTCCCAGT 
208 CACGACGT TTTT GTAATGGG ATAGGTCAAAACGGCG 
209 GATTGACC TTTT GATGAACG GTAATCGTAGCAAACA 
210 AGAGAATC TTTT GGTTGTAC CAAAAACAAGCATAAA 
211 GCTAAATC TTTT CTGTAGCT CAACATGTATTGCTGA 
212 ATATAATG TTTT CATTGAAT CCCCCTCAAATCGTCA 
213 TAAATATT TTTT GGAAGAAA AATCTACGACCAGTCA 
214 GGACGTTGTTTTTCATAAGGGAACCGAAAGGCGCAG 
215 ACGGTCAATTTTGACAGCATCGGAACGAACCCTCAG 
216 
CAGCGAAAATTTTACTTTCAACAGTTTCTGGGATTTTGCTAAA
C TTTT 
Loop1 AACATCACTTGCCTGAGTAGAAGAACT 
Loop2 TGTAGCAATACTTCTTTGATTAGTAAT 
Loop3 AGTCTGTCCATCACGCAAATTAACCGT 
Loop4 ATAATCAGTGAGGCCACCGAGTAAAAG 
Loop5 ACGCCAGAATCCTGAGAAGTGTTTTT 
Loop6 TTAAAGGGATTTTAGACAGGAACGGT 
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Table 4.1 (Continued) 
Loop7 AGAGCGGGAGCTAAACAGGAGGCCGA 
Loop8 TATAACGTGCTTTCCTCGTTAGAATC 
Loop9 GTACTATGGTTGCTTTGACGAGCACG 
Loop10 GCGCTTAATGCGCCGCTACAGGGCGC 
 
Modified Strands (Morse Code).  
Table 4.2 Thiol modified staple strands / Morse Code: 
 
 
 
 
 
 
 
 
 
 
 
Sequence Name Sequence (5'‐3')
HS‐16 GCTCATTTTCGCATTA AATTTTTG AGCTTAGA
HS‐32 GTTTGCCACCTCAGAG CCGCCACCGATACAGG
HS‐38 TATTTTGCTCCCAATC CAAATAAGTGAGTTAA
HS‐44 CTGTAAATCATAGGTC TGAGAGACGATAAATA
HS‐56 TCGGCATTCCGCCGCC AGCATTGACGTTCCAG
HS‐62 AGGTTTTGAACGTCAA AAATGAAAGCGCTAAT
HS‐68 AAATCAATGGCTTAGG TTGGGTTACTAAATTT
HS‐128 CTCATCTTGAGGCAAA AGAATACAGTGAATTT
HS‐194 TTTTTGCGCAGAAAAC GAGAATGAATGTTTAG
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Table 4.3 Biotin modified staple strands / Morse Code: 
 
DNA Sequences (Uppercase I / Lowercase i) 
Table 4.4 Biotin modified staple strands / (I/i) : 
 
 
 
 
 
 
Sequence Name Sequence (5'‐3')
Bio‐50 GAATGGCTAGTATTAA CACCGCCTCAACTAAT
Bio‐74 GCGTAAGAGAGAGCCA GCAGCAAAAAGGTTAT
Bio‐112 CCGAAATCCGAAAATC CTGTTTGAAGCCGGAA
Bio‐123 TTTTAATTGCCCGAAA GACTTCAAAACACTAT
Bio‐134 GAATAGCCGCAAGCGG TCCACGCTCCTAATGA
Bio‐140 AAATAATTTTAAATTG TAAACGTTGATATTCA
Bio‐146 GAAGCAAAAAAGCGGA TTGCATCAGATAAAAA
Bio‐152 GCGAAACATGCCACTA CGAAGGCATGCGCCGA
Bio‐182 TGGACTCCCTTTTCAC CAGTGAGACCTGTCGT
Bio‐188 ACCCGTCGTCATATGT ACCCCGGTAAAGGCTA
Bio‐200 GCTCCATGAGAGGCTT TGAGGACTAGGGAGTT
Bio‐206 TATCAGGG TTTT CGGTTTGC GTATTGGGAACGCGCG
Bio‐209 GATTGACC TTTT GATGAACG GTAATCGTAGCAAACA
Bio‐212 ATATAATG TTTT CATTGAAT CCCCCTCAAATCGTCA
Bio‐215 ACGGTCAA TTTT GACAGCAT CGGAACGAACCCTCAG
Sequence Name Sequence (5'‐3')
Bio‐14 CTAATTTATCTTTCCT TATCATTCATCCTGAA
Bio‐37 ATTATTTAACCCAGCT ACAATTTTCAAGAACG
Bio‐40 TAAGTCCTACCAAGTA CCGCACTCTTAGTTGC
Bio‐59 ATACCCAAGATAACCC ACAAGAATAAACGATT
Bio‐61 TTTTGTTTAAGCCTTA AATCAAGAATCGAGAA
Bio‐124 AAGAGGAACGAGCTTC AAAGCGAAGATACATT
Bio‐144 TCAATTCTTTTAGTTT GACCATTACCAGACCG
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Table 4.5 Thiol modified staple strands  / (I/i): 
 
Desthiobiotin modification of thiol-DNA. The concentration of DNA was 
calculated based on absorption at 280 nm according to the Beer-Lambert law. and 
adjusted to 100 µM. A 10 µM solution of 5` thiol modified DNA (used as received from 
IDT) was incubated with 2 µL of tributylphosphine solution for 2 hours at room 
temperature to the reduce the disulfide bond. Next, a 35 mM solution of desthiobiotin 
polyethyleneoxide iodoacetamide was freshly prepared in a 1 x TAE-Mg2+ buffer (Tris, 
40 mM; acetic acid, 20 mM; EDTA, 2 mM; and magnesium acetate, 12.5 mM; pH 8.0) 
and incubated for 5 hours at 50 °C. Excess linkers were removed by washing 10 times 
with water using a 30 MWCO Amicon centrifugal filter. To purify the desthiobiotin 
functionalized product, the washed and concentrated solution was incubated with avidin 
agarose beads and eluted following manufacturers suggested protocols.  
Non-denaturing PAGE. Gels containing 4% polyacrylamide (19:1 acrylamide/ 
bisacrylamide) were run on an Owl Adj2 electrophoresis unit at 4 °C (4 W, constant 
Sequence Name Sequence (5'‐3')
HS‐11 CCTAATTTACGCTAAC GAGCGTCTAATCAATA
HS‐57 AATCACCAAATAGAAA ATTCATATATAACGGA
HS‐63 CAAGCAAGACGCGCCT GTTTATCAAGAATCGC
HS‐65 CATATTTAGAAATACC GACCGTGTTACCTTTT
HS‐121 TTTCATTTGGTCAATA ACCTGTTTATATCGCG
HS‐147 TCAGAAGCCTCCAACA GGTCAGGATCTGCGAA
HS‐164 CTTTCATCCCCAAAAA CAGGAAGACCGGAGAG
HS‐166 GGTAGCTAGGATAAAA ATTTTTAGTTAACATC
HS‐168 CAATAAATACAGTTGA TTCCCAATTTAGAGAG
HS‐170 TACCTTTAAGGTCTTT ACCCTGACAAAGAAGT
HS‐172 TTTGCCAGATCAGTTG AGATTTAGTGGTTTAA
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wattage). The running buffer was 1x TAE-Mg2+ buffer. After electrophoresis, the gels 
were stained with ethidium bromide (Sigma) and imaged under UV illumination. DNA 
recovery was done by cutting and soaking gel pieces with 1x TAE-Mg2+ buffer for 12 
hours at 4 °C. 
Design and assembly of DNA origami. Rectangular origami tiles were formed 
according to Rothemund’s paper with a ratio of 1:20 between viral DNA and both 
modified and unmodified staple strands. A concentration of 10 nM viral DNA was used in 
this work. Helper strands were mixed to form a master mix (50 µM) that was added to the 
viral DNA sequence in 1x TAE-Mg2+ buffer and annealed from 90 °C to 20 °C over 3 
hours. After assembly of the origami tiles, they were washed 3x with 1x TAE-Mg2+ and 
concentrated using Amicon centrifugal filter units (100 MWCO, 300 x g speed, 10 min).  
Conjugation of proteins to DNA origami template. To demonstrate selective 
release of protein from origami template, the protein decorated tiles were diluted to 1 mL 
and dialyzed overnight in a 300,000 MWCO membrane to remove the large excess of 
streptavidin that was necessary to prevent aggregation in the previous incubation step. 
The sample is then treated with 3 mM of biotin solution in 1x TAE-Mg2+  for 2 hours at 
room temperature before dialyzed with 1 mM biotin for 24 hours at 4 °C. The final 
solution is washed several times with 1x TAE-Mg2+ to remove excess biotin and 
concentrated to 30 µL using a 100,000 MWCO membrane.  
AFM imaging.  A drop of 3 ul DNA solution was spotted onto freshly cleaved 
mica surface, and kept for 10 s to achieve strong adsorption. 30 µL of 1x TAE-Mg2+ was 
added to the mica surface and the tip was pre-wet to prevent drift during imaging. Fluid 
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imaging was performed using nitride probes having a resonance frequency of 21-52 kHz 
(Olympus -TR400PSA). The tip–surface interaction was minimized by optimizing the 
scan set-point to the highest possible value. AFM imaging was performed at 22 °C. AFM 
data was processed with IGOR Pro software. 
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4.6  Figures 
 
 
Figure 4.1 A) Chemical structures and schematic illustrations of the competitive binding 
between biotinylated and desthiobiotinylated DNA strands toward biotin; B) Native gel 
shift assay showing biotinylated and desthiobiotinylated DNA strands before (lanes 1,2 
respectively), after incubation with streptavidin (lanes 3,4 respectively), and then after 
treatment with excess biotin (lanes 5,6 respectively). 
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Figure 4.2 Matrix assisted laser desorption / ionization mass spectrometry (MALDI-MS) 
of unmodified, unpurified DNA strand with an observed mass of 10092 and10225 (left) 
and after modification with an observed mass of 10534-10756 (right), which corresponds 
well with the successful conjugation of the desthiobiotin linker, with an expected mass of 
456.46 g / mol. 
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Figure 4.3 Initial design and characterization of the nano-morse code. To reduce the 
number of modifications necessary to form the code, only half of the DNA tile was used. 
The tile is a 100 nm x 70 nm rectangular tile made up for the mp13 bacteriophage DNA 
and 226 short stable strands (A-C). AFM characterization revealed that it was difficult to 
distinguish between a single protein and two adjacent proteins due to the small 
separations. 
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Figure 4.4 An illustration of the final design of encrypted and decrypted Morse code 
designs displaying the nonsense coded message “OOOO” and the hidden message 
“NANO” A) AFM images of tiles displaying encrypted message “OOOO” and (B) 
decrypted Morse code message “NANO” after biotin addition. Scale bar = 70 nm. 
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Figure 4.5 (A) Design of an uppercase “I” and lower case “i” as revealed by atomic force 
microscopy. (B) First incubation of functionalized tiles with streptavidin, revealing the 
capital “I” feature. (C) Subsequent incubation with excess biotin selectively removes 
streptavidin bound to desthiobiotin modifications, revealing the lower case “i.” (D) After 
washing, newly introduced streptavidin is allowed to bind to free desthiobiotin sites, 
recovering the capital “I” pattern on the DNA tile. Scale bar = 70 nm. 
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Figure 4.6 Large area atomic force microscope image of encoded nano-Morse code with 
zoomed in images of 8 well-formed tiles.  
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Figure 4.7 Large area atomic force microscope image of decoded nano-Morse code with 
zoomed in images of 8 well-formed tiles. 
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CHAPTER 5 
FACILE, PHOTOSTABLE, AND MONODISPERSED DNA 
MEDIATED NANOFLOWERS AS OPTICAL CONTRAST IMAGING 
AGENT FOR DIRECTED UPTAKE AND IMAGING OF CANCER 
AND TUMOR CELLS 
5.1  Introduction 
The characterization of nano-bio interactions and successful application of 
nanosized materials for the next generation of biomedical therapies is poised to be one of 
the greatest developments in the 21st century. The goal of this research is to design and 
engineer a class of carriers that is capable of navigating the body, infecting and 
transforming cells, or detecting and repairing diseased cells. In order to realize these 
goals, we must develop an in depth understanding of nano-bio interactions and carry out 
standardized and complete characterization of nanomaterials across a wide range of 
materials, shape, size, and surface chemistry. Unfortunately, one of the major 
shortcomings of nano-bio research has been the proliferation of “proof-of-concept” 
demonstrations that have so far, been difficult to correlate in a complete, useful database. 
Fortunately, despite a lack of standardized experiments, some general nano-bio trends 
have been elucidated and validated. 
For a majority of nano-bio platforms, a prototypical nanoparticle is first 
chemically synthesized, then the surface is modified with one or more polymer, drug, 
fluorophore, peptide, proteins, or oligonucleotide, and their uptake by cell cultures (in 
vitro) or various animal models (in vivo) are characterized and reported. Here we briefly 
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highlight some of the more important nano-bio concepts such as multivalency, size, 
shape, and surface charge, as factors within the overall parameter of “uptake efficiency.” 
 The multivalency effect is the idea that the binding strength and uptake of a 
particle is enhanced if more than one ligand on a particle binds to multiple targeted 
receptors of a cell. This effect was observed by Jiang et al. (1) using antibody decorated 
nanoparticles and Walsh et al. (2) via aptamer decorated DNA tetrahedrons. Jiang and 
coworkers varied the density of Herceptin on a gold nanoparticle surface by varying the 
curvature of the particle. In their report, the binding affinity of Herceptin to the ErbB2 
receptor is 10−10 M in solution, 5.5 × 10−12 M on a 10-nm nanoparticle, and 1.5 × 10−13 M 
on a 70-nm nanoparticle. Interestingly, they also reported that downstream signaling via 
the ErbB2 receptor was strongest with 40-50 nanometer particles, demonstrating 
additional effects must be considered beyond ligand density. Recently Walsh et al 
elegantly confirmed this finding through the use of DNA tetrahedrons (see chapter 3 of 
this theis). By controlling the number of ligands (DNA aptamers) at each vertex of the 
nanostructure, they were able to vary the orientation and the density of ligands and 
reported that a minimum of three ligands, oriented in the same direction, was necessary 
for maximum uptake. Interestingly, they also reported that additional ligands did not 
increase the uptake efficiency of the nanostructures.  
 It has long been recognized that particle size and shape were important factors in 
determining the final uptake efficiency. Gratton et al. demonstrated elegantly similar 
sized nanoparticles with different shapes significantly impact the uptake. In his work, 
Gratton and coworkers show that above 100 nanometers, nanorods demonstrate the 
highest uptake, followed by spheres, cylinders, and cubes. Interestingly, in studies with 
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sub-100-nm nanoparticles, spheres show an advantage over rods. (3,4) At size scales 
below 100 nanometers, it was reported that increasing the aspect ratio of nanorods will 
decrease total cell uptake. Although few studies have focused on nonspherical 
nanoparticles thus far, research indicates their interactions with cells may be much more 
complex. Ligand-coated rod-shaped nanoparticles may present to the cell with two 
different orientations. Compared with the short axis, the long axis will interact with many 
more cell surface receptors. (5) For spiky nanostructures such as gold nanourchins, 
whether the ligand is located on or between the spikes affects how it is presented to the 
target cell receptors (6). From these investigations, it can be concluded that non-spherical 
and asymmetric particles demonstrate more complex nano-bio interactions but also 
allows more control over engineering desired uptake properties. Above, it was noted that 
nanoparticles with at roughly 50 nanometers exhibited the most effective uptake 
properties. A possible explanation for this phenomenon arises from the formation of 
vesicles during receptor mediated endocytosis. When one or more targeting ligands bind 
to surface receptors, the nanoparticle causes a localized decrease in the Gibbs free energy 
which triggers wrapping of the membrane and the formation of vesicles by the cell. It can 
be calculated that nanoparticles at roughly 50 nanometers can bind enough receptors to 
successfully promote membrane wrapping. (7) At sizes above 50 nanometers, the 
nanoparticles may bind such a large number of receptors that total uptake is then limited 
by the redistribution of receptors on the cell surface to accommodate the binding of 
additional nanoparticles. Similarly, nanoparticles below 50 nanometers may not bind 
enough receptors to efficiently promote the wrapping of the membrane to form vesicles. 
Since most of the work in this field has demonstrated such proof of concept work using 
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immortalized cell lines, and each cell type possesses a unique phenotype with varying 
levels of target receptors and internalization pathways, it will become increasingly 
important to fully characterize the uptake with both immortalized as well as primary cells 
in different cell culture configurations. A standardized panel of cells and conditions 
would provide a roadmap toward creating a large, compatible library of information that 
will allow researchers to generate, test, and validate significant trends or mechanism.  
 As briefly mentioned above, gold nanoparticles have become one of the bedrocks 
of nano-biotechnology research. It processes excellent stability, biocompatibility, and a 
large library of available surface modifications that is often desired for in vitro and in 
vivo studies. A close analogy to the size and shape dependency of nanoparticle 
physiochemical properties, the uptake of nanoparticles by cells is highly dependent on the 
shape, size, and surface functionality/charge. Towards shape-controlled nanoparticle 
synthesis, molecular capping agents such as organic surfactants and polymers have been 
used to direct nanocyrstal growth in a face selective fashion. (8,9) Despite tremendous 
progresses made, the mechanism of the shape control is not well understood, in part due 
to the difficulty in defining structures and conformations of these surfactants and 
polymers in solution and in systematic variation of functional groups. DNA is a well-
known biopolymer with more defined structure and conformation in solution and unique 
programmable nature to tune its functional properties. (10-13) Because of these 
advantages, DNA has been used as template to position nanoparticles through DNA 
metallization (14,15), or nanoparticle attachment (13,16-20), or to control the sizes, and 
the photo-luminescent property of quantum dots. (21-27) In a previous publication, Wang 
et al. (28) demonstrated the synthesis of a DNA template gold nanoflower that 
125 
 
highlighted the base dependent interaction between nucleotides, gold nanoparticle 
surface, and oligonucleotide driven reduction of gold ions onto a gold particle seed. In the 
experiment, Wang et al. demonstrated for the first time that DNA can be used to tune gold 
nanoparticle morphology in a sequence dependent manner, suggesting that biomolecules 
can play a significant role in shaping nanoparticles. Furthermore, DNA functionalization 
with high stability was realized in-situ during the one-step synthesis while retaining their 
bio-recognition ability. We have also shown that the DNA functionalized nanoflowers can 
be readily uptaken by cells and visualized under dark-field microscopy. 
One of the major advantages of above mentioned gold nanoflowers is its high 
scattering profile when viewed under dark-field optical microscopy. Traditional cell 
labeling and imaging is done using a library of small molecule fluorophores and dyes. 
However, these dyes suffer from severe photobleaching effects where the dye is rapidly 
degraded under irradiation and their visualization often requires expensive light sources 
and specialized filters. By using a contrast agent that is biocompatible, does not require 
special illumination, and does not suffer from photo-degradation, the imaging and 
identification of specific cell types becomes more standardized and more widely 
available. The other major advantage of the current technique is the simplicity of the 
functionalization and the expected stability of the functionalization.  
In the following work, we hypothesize that we are able to incorporate the newly 
discovered nanoflower structure with a cancer specific aptamer sequence (NCL / 
AS1411) that exhibit high affinity and specificity toward nucleolin, a protein known to be 
overexpressed on the surface of several cancer cell lines, such as MCF-7, an 
immortalized human breast cancer cell line. We are also interested in exploring the shape 
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and size dependent uptake of nanoflowers, especially compared to similarly sized 
nanoparticles. The goal is to develop a simple nanoparticle platform that is easy to 
produce via a one-step synthesis, with a highly stable aptamer functionalization, 
demonstrate improved uptake over spherical nanoparticles, and can be used for imaging, 
diagnosis, and therapy of cancer and other diseased cells.  
5.2 Results and Discussion 
 Previous work by Storhoff (29) and Wang (30), have clearly demonstrated that the 
interaction between nucleic acid and oligonucleotides are sequence dependent with 
adenosine (A) and cytosine (C) showing high interaction and physical adsorbtion onto 
gold surfaces and tyrosine (T) showing a significantly lower interaction. Guanine (G) was 
not considered in the current work due to significant secondary structures when multiple, 
consecutive guanines are present within an oligonucleotide. (31) This was further 
demonstrated by Wang et al. when he showed that DNA induced formation of gold 
nanoflowers was observed only in the presence of a 30 adeonsine repeat (30-A) and a 30 
cytosine repeat (30-C) oligonucleotide. It is noted that a 15-T and 15-A sequence did not 
produce a high quality nanoflower structure, indicating that the gold-nucleotide 
interaction is cumulative over the sequence and a minimum number of cytosine or 
adenosine is needed for strong adsorption. Taking these factors into consideration, two 
final oligo designs were tested. Since the AS1411 aptamer is a GC rich oligo and likely 
forms a secondary structure related to its specific binding to nucleolin, the interaction of 
the aptamer sequence with gold nanoparticles can be considered minimal. To confirm 
this, the aptamer sequence was incubated with 20 nm gold nanoparticles and upon 
addition of a reduc tant (NH4OH) and gold source. UV-Vis and TEM confirm that the as-
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grown nanoparticles remained spherical, a good indication that the interaction between 
the aptamer sequence and gold surface is negligible. Based on these observations, the 
first aptamer construct was a simple hybrid of a 30 repeat of cytosine or adenosine with 
the aptamer sequence. These sequences were named 30C-AS1411 and 30C-Control. 
However it is important to consider that during the nanoflower growth process, part of 
the oligonucleotide on the surface will become entrapped within the growing gold layer, 
possible disturbing the structure and functionality of the aptamer sequence. To 
compensate, a second construct incorporate a 15-T spacer between the gold binding 
region and the aptamer within the oligonucleotide sequence. These constructs were 
named 30C-15T-AS1411 and 30C-15T-Control. Lastly, in the event that the aptamer 
cannot be freed from the growing gold layer, a 5` end modified aptamer with a 5T spacer 
was tested as a post-synthesis functionalization. This sequence will be used also to 
functionalize spherical corresponding sizes of gold nanospheres to investigate a potential 
difference in size dependent uptake.  
 One of the most important parameters that affect cell uptake efficiency is 
nanoparticle size. Chithrani et al. showed that spherical gold nanoparticles 40-50 nm 
achieved optimal cellular uptake by HeLa cells. (3) In addition to size, it will become 
important to investigate many other factors such as material, shape, surface 
modifications, and cell types to elucidate their role in cellular uptake of DNA 
functionalized nanoflowers. To determine the best method to control size of gold 
nanoflowers, we designed two parallel experiments: seed based and growth based. Since 
the nanoflower growth process is one that is defined by 3 factors: gold seed size, gold 
seed concentration, and gold salt concentration. By first holding seed size constant (20 
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nm) and varying the gold salt (AuCl4) concentration from 0.003% to 0.016% w/v, we 
were able to observe a linear increase in nanoflower size from ~35 to 50 nm diameter as 
determined by transmission electron micrographs. All values were calculated from 
averages diameters of 50 particles as measured from tip to tip as well as by dynamic light 
scattering (DLS). Transmission electron micrographs confirm similar trends using both 
oligonucleotide constructs, with both AS1411 as well as a randomized control sequence. 
Of note, nanoflower size homogeneity decreased with increasing nanoflower growth. 
 As mentioned, during the growth of the nanoflower, the growing gold layer 
engulfs a portion of the DNA strand. Therefore, to maximize the probability of the 
complete aptamer sequence remaining exposed post-synthesis, it is important to optimize 
the growth process to achieve the desired physical and optical properties while 
minimizing the gold growth needed. To achieve this, we successfully demonstrated the 
size control of nanoflowers by establishing the minimum growth condition for 10, 20, 
and 40 nm gold nanoparticle seeds as confirmed by dynamic light scattering, UV-Vis, 
and TEM. Of note, nanoflowers generated with 50 nm and larger seed particles did not 
form uniform nanoflowers and were unstable in water. This is likely because the physical 
adsorption of oligos was not sufficient in stabilizing the particle during the growth. The 
minimum growth condition is defined as the lowest AuCl4 concentration that completely 
shifted the 520 nm absorption peak of a spherical gold nanoparticle into the characteristic 
absorption peak of the corresponding nanoflower. It was reported that the interaction 
between specific nucleotides and the gold surface can lead to the growth of sequence 
specific shapes, additionally, during this set of experiment we find that the size of the 
nanoflowers is limited by the length of the DNA strand. In particular, it was observed that 
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when poly-A(30) sequence was used, a 20 nm seed nanoflower cannot be growth with 
high yield and monodispersed at sizes less than 33 nm. On the other end of the spectrum, 
poly-A(30) cannot be used to grow stable nanoflowers above 50 nm, or the nanoflowers 
quickly aggregates and precipitates from the solution. However, when a much longer 71 
base pair strand, such as the 30T-15C-APT or 30T-15C-CTRL sequence, is used to direct 
nanoflower growth, the size of the gold nanoflowers can be grown to greater than 200 nm 
while remaining stable in solution for greater than 6 months.  
 An important consideration for any nanoparticle system destined for in vitro and 
in vivo applications is the stability of the nanoparticles in biological or biologically 
relevant fluids. Previous work by Storhoff (29), Petrovykh (32), Wang (33), and others 
have demonstrated and studied the capacity of both chemically or physically bound layer 
of oligonucleotides to protect nanoparticles from aggregation and degradation in high 
salt, complex environments. In particular, Mirkin’s group has developed a strategy for 
decorating nanoparticles with an extremely dense layer of DNA that demonstrates 
excellent thermal and biochemical stability. To better understand the stability of the 
aptamer functionalized nanoflowers, all design constructs were diluted and incubated in 
1x OPTIMEM at 37 °C for 2 hours. The nanoparticles were then washed 3x in Millipore 
water by centrifugation and resuspended in Millipore water and analyzed by UV-Vis. As 
synthesized, both constructs (30C-AS1411 and 30C-15T-AS1411) showed signs of 
aggregation post incubation as demonstrated by a shift in UV-Vis absorption spectrum. 
Two strategies to increased nanoflower stability were tested, increasing the density of 
DNA on nanoflower surface, and post-synthesis PEGylation.  
 The density of oligo functionalization on a nanoparticle surface directly correlates 
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to the stability of the nanoparticle and its cellular uptake properties. (34,35)  This was 
done by increasing the NaCl concentration from 0 mM to 200 mM over 24 hours during 
the DNA incubation with gold nanoparticle seed. By slowly increasing the concentration 
of NaCl in the incubation buffer, the highly negative oligonucleotides were increasingly 
screened from each other, theoretically allowing more oligos to be immobilized onto the 
surface. After the DNA incubation process, the nanoflowers synthesis proceeded as 
previously described. Increased stability of high density DNA nanoflowers were 
demonstrated by challenging as-synthesized nanoflowers and high density DNA 
nanoflowers to a 300 mM NaCl solution and incubated at room temperature for 1 hour. 
As seen from optical observation and UV-Vis characterization, after incubation in a 300 
mM NaCl solution for 1 hour, the as-synthesized nanoflowers aggregated and settled to 
the bottom of the tube while the high density DNA nanoflowers retained the 
characteristic blue-ish color. UV-Vis and electron micrographs further confirm the 
stability of the high density DNA nanoflowers. However, when challenged with 1x 
OPTIMEM, the high density DNA nanoflowers also appears to aggregate after a 2 hour 
incubation at 37 °C.  
 A second technique, post synthesis PEG functionalization was also carried out. 
After nanoflower synthesis, the nanoflowers were washed 3x by centrifugation in DI 
water and resuspended in a conjugation buffer. SH-PEG (MW 1000) was added and kept 
for 2 hours before washing 5x in DI water. PEGylated and non-PEGylated DNA 
nanoflowers were then resuspended in OPTIMEM for 2 hours at 37 °C. UV-Vis data 
shows that the PEGylated nanoflowers did not experience a shift in its absorption peak, 
indicating good stability while the non-PEGylated nanoflowers showed peak shift and 
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broadening that is characteristic of nanoparticle aggregation. The addition of PEG post-
synthesis significantly enhanced the stability of the nanoflowers in cell media and no 
aggregation was observed when the nanoflowers were suspended in Opti-Mem for 2 
hours.  
 Finally, it is possible that the growth of the nanoflowers will partially or 
completely block the aptamer and reducing or eliminating its target recognition ability. 
Therefore, as a backup we also decorated pre-synthesized nanoflowers with thiolated 
aptamers. The nanoflowers were treated first with a polyA-30 oligonucleotide, grown into 
nanoflower shapes, and then finally decorated with aptamers. This technique guarantees 
the availability of the aptamers on the surface of the nanoflowers for target specific 
binding.  
 In addition to demonstrating the cell specific uptake of the nanoflowers by cancer 
cells, we were interested in the uptake characteristic of a nanoflower shaped particle 
versus the more traditional nanospheres that are widely used today. Chithrani et al. (3) 
reported in 2006 that in vitro uptake of nanospheres are size dependent, where 40 
nanometer particles are most readily taken up by cells. Additionally, for in vivo 
applications, it has been reported and confirmed that nanoparticles from 40 nm to 200 nm 
exhibit the longest half-life in the blood stream due to their ability to avoid the liver. A 
similar study was also reported for the size dependent uptake of nanorods in cells. 
Therefore, we were interested in the size dependent uptake behavior of nanoflower 
shaped particles as well nanoflower uptake efficiency compared with spherical 
nanoparticles under similar conditions.  
Targeted uptake in vitro. To understand the cellular uptake properties of the DNA 
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nanoflowers and whether it is able to achieve selective uptake through aptamer 
recognition, we choose to work with MCF-7 cells, a human breast cancer cell line, as a 
model cell system. This particular cell line overexpresses the nucleolin protein on the cell 
surface and which can be effectively targeted by the AS1411 aptamer. One of the main 
advantages of the nanoflower structure is its high scattering profile when viewed under 
dark field microscopy as first reported by Wang et al. Therefore, uptake experiments are 
characterized by bright and dark field microscopy and quantified using transmission 
electron microscopy and ion-coupled plasma mass spectroscopy (ICP-MS).  
The nanoflowers synthesized by each of the three techniques described above 
were incubated with MCF-7 cells to determine their cellular uptake properties.  
Following the original hypothesis, we prepared a series of nanoflowers grown 
using a single DNA strand which consists of three sub-segments: anchor (poly-C-30), 
spacer (poly-T-15), and the targeting aptamer (or control sequence). The 71 base pair 
sequence is incubated with a 20 nanometer gold particle seed for 20 minutes, and grown 
into ~ 35 nanometer gold nanoflower structures. As figure XX shows, below 30 
nanometers, the size distribution of the nanoflowers increased dramatically and a 
percentage of the nanoparticles remained in spherical, rather than flower shaped. 
Therefore, given this minimum size restriction, the MCF-7 cell cultures were incubated 
with the nanoflowers for 2 hours. Under the optical microscope, it can be observed that 
there is a high background from non-specific binding of nanoparticle aggregates on the 
bottom of the plate. While there seems to be some increase in the aptamer functionalized 
nanoflowers to the MCF-7 cells, due to the significant background signal and 
aggregation, this system was not pursued further. 
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Next, as mentioned above, we reasoned that the stability of the nanoflowers could 
be increased by either increasing the density of the DNA on the surface of the 
nanoparticle, or by backfilling the nanoflower surface with polyethylene glycol. The first 
strategy is one that has been perfected by the Mirkin group at Northwestern. By slowly 
increasing the salt concentration while incubating gold nanoparticles with thiolated DNA, 
Dr. Mirkin has successfully demonstrated highly dense packing of DNA on gold 
nanoparticles which exhibit extraordinary stability and interestingly, a much sharper 
melting temperature than a normal double stranded DNA. Following this model, we 
hypothesized that by increasing the density of the DNA coverage on the surface of the 
particle, we would accomplish two goals simultaneously. The first was to increase the 
density of DNA coverage to increase the stability of the nanoflowers. The second was 
that increasing the density of the coverage meant that the spacer portion of the DNA 
(with lower DNA-gold binding affinity) would be crowded off the surface of the gold by 
the presence of more anchoring strands (with higher DNA-gold binding affinity), this in 
turn, would increase the distance between the targeting aptamer sequence to the growing 
gold surface, thus increasing the likelihood that the aptamer would be intact post-
synthesis. The second strategy to improve the stability was by post-functionalization of 
the nanoflowers by conjugating a thiolated PEG to the surface. A short 1000 MW HS-
PEG was used to minimize the chances of the PEG blocking the activity of the aptamer. 
Both nanoflowers in these experiments were grown from 20 nm gold particle seeds to 
roughly 35 nanometer gold nanoflowers. 
Figure 5.3 shows the results of the uptake experiment with nanoflowers grown by 
increasing the salt concentration slowly from 0 mM to 75 mM while the nanoparticle 
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seeds were incubated with DNA. In this case, we observe a seemingly large difference 
between the aptamer and control samples with a decreased level of aggregates visible in 
the sample. However two things were of concern, first, we observe that there is 
significant non-specific binding in the aptamer functionalized samples and the second is 
that the brightness levels were disproportionate with the number of visible uptaken 
particles. This was later confirmed as an imaging irregularity. Repeated experiments 
show the presence of non-specific binding and this strategy was no longer pursued. 
Next, Figure 5.4 shows the results of the uptake experiments with nanoflowers 
post-functionalized with polyethylene glycol to increase the stability of the nanoflowers. 
We observe under bright and dark field imaging that indeed both the aptamer 
functionalized and control nanoflowers had significantly reduced background, non-
specific binding as well as complete absence of aggregation as seem in previous samples. 
Unfortunately, there was no obvious difference in the uptake of the aptamer 
functionalized nanoflowers versus the nanoflower with control sequences. At this point, it 
was assumed that the growth of the nanoflower with a single strand strategy, while 
ideally more simple, was not a feasible strategy. Finally, as a positive control experiment, 
MCF-7 cell cultures were incubated with PEG protected, control sequence nanoflowers 
for 24 hours. Figure 5.2 shows properly uptaken nanoflowers in darkfield scattering 
mode, with little aggregation and non-specific binding visible in either darkfield or bright 
field microscopy.  
The last strategy was a post-synthesis with thiolated aptamer and control 
sequence. While this strategy does not offer the advantage of increased stability of the 
aptamer by virtue of a physical incorporation of the sequence into the nanoflower 
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structure, it does offer better control of the nanoflower growth (with a simple, poly-A 
strand), guaranteed availability of the aptamer, and a path to study shape and size 
dependent uptake of nanoflowers with multiple cell types. The experiment following 
consisted of comparing nanoflowers and nanoparticles of 4 different sizes, 20 nm, 40 nm, 
60 nm, and 80 nm, decorated with either the AS1411 aptamer sequence or control 
sequence.  
Before describing the growth the various sizes of nanoflowers, there was an effort 
to reduce the dispersity of the synthesized nanoflowers. In the previous described 
procedure by Wang et al. the synthesis process involved adding a small volume (~1 µL) 
of a high concentration of gold salt (1% w/v) into a relative small volume of gold 
nanoparticles (~300 µL). This was suitable for the particular system that was described 
by Wang et al., however, when the same procedure was used to synthesize a board range 
of sizes of nanoflowers, the poly-dispersity of the product was quite high, as confirmed 
by both DLS and TEM imaging. To address these issues, the hypothesis was that the 
polydispersity was caused by the very quick reaction that was taking place to grow the 
nanoflowers. By increasing the overall volume of the system, reducing the concentration 
of gold nanoparticles, reducing the concentration of reduction agent, and reducing the 
stock concentration of gold stock, would slow the reaction down enough to achieve 
uniform mixing before significant growth of the nanoflowers occurred. After 
optimization, a general procedure for highly monodispersed nanoflowers across a large 
size spectrum was established. Briefly, a 100 µL stock solution of gold nanoparticles was 
diluted in 500 uL of Millipore water and incubated with 3 µM of DNA for at least 20 
minutes at room temperature. Next, 500 µL of Millipore water was added to a NaOH 
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treated glass vial and 30 uL of 400 mM hydroxylamine hydrochloride were added. Next, 
the gold nanoparticle solution was added to the glass vials. While under vortex (setting 
between 7 and 8), a variable volume of 0.01% w/v gold salt solution was added quickly 
and the solution was vortex vigorously for 15 minutes to allow the complete reduction of 
gold salt onto gold nanoparticle seeds.  
To synthesize 20 nanometer gold nanoflowers, we start with a 10 nm seed; 
incubate with a 3 µM poly-A30 DNA sequence and varied the gold salt from 100 µL to 
400 µL. The resulting nanoflowers followed a linear trend from 18 nm to 28 nm, with 
300 µL corresponding to a 20 nm nanoflower. Synthesized nanoflowers were 
characterized by UV-Vis, DLS, and TEM imaging. It is of note that nanoflowers using 
seeds below 10 nm does not lead to smaller nanoflower structures, rather small amounts 
of nonspecific aggregation occurs and links the small nanoparticle seeds into amorphous 
structures. The 20 nm gold nanoflowers also exhibited a slightly different structure then 
its larger counter parts, namely each nanoflower shows only 2-3 ‘spikes’ rather then  
To synthesize 40 nanometer gold nanoflowers, we start with a 20 nm seed; 
incubate with a 3 µM poly-A30 DNA sequence and varied the gold salt from 100 µL to 
400 µL. The resulting nanoflowers followed a linear trend from 35 nm to 45 nm, with 
400 µL corresponding to a 40 nm nanoflower. Synthesized nanoflowers were 
characterized by UV-Vis, DLS, and TEM imaging. 
To synthesize 60 nanometer gold nanoflowers, we start with a 40 nm seed; 
incubate with a 3 µM poly-A30 DNA sequence and varied the gold salt from 100 µL to 
400 µL. The resulting nanoflowers followed a linear trend from 55 nm to 80 nm, with 
250 µL corresponding to a 60 nm nanoflower. Synthesized nanoflowers were 
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characterized by UV-Vis, DLS, and TEM imaging. TEM characterization is summarized 
and presented in Figure 5.6. 
The nanoflowers are then washed at least twice by centrifuge before storing in a 
NaOH treated 20 mL scintillation vials. In the following experiments, 1X concentration 
represents 100 µL of original stock nanoparticles per 500 µL final volume. The 1X 
concentrated nanoparticles are then incubated with thiolated DNA (previously treated 
with 0.4 mM TCEP for 1 hour in 5.2 pH phosphate buffer). After 16 hours, 30 µL of pH 
8.2 phosphate buffer is added dropwise, followed by 300 µL of 1 M NaCl, added 
dropwise. The nanoparticles are stored for another 16 hours before use. Corresponding 
sizes of gold nanoparticles were functionalized similarly and stored in NaOH treated 20 
mL scintillation vials. Prior to incubation, an appropriate amount of nanoparticles is 
transferred to a 2 mL centrifuge tube and centrifuged at 11k RPM for 20 minutes to 
remove excess salt.    
The synthesized nanoflowers and correspondingly sized nanoparticles were then 
incubated with MCF-7 and LnCaP cell cultures to determine uptake profiles. The 
nanoflowers and nanoparticles were pelleted by centrifugation and dispersed in 1X Opti-
Mem and introduced to cells grow on cover slips inside 6 well plates. Maintaining a 
constant incubation time of 2 hours, the concentration was varied from 1X concentrated 
to 5X concentration.  
MCF-7 cell cultures were grown on sterilized glass cover slips in 6 well plates for 
overnight before uptake experiments. After incubating for 2 hours with 3X concentrated 
gold nanoparticles in 1X Opti-Mem  cell culture media, the cells were washed three times 
in 1X PBS and fixed by incubating in 4% PFA in 1X PBS for 20 minutes at room 
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temperature. The coverslips were placed onto glass slides and characterized using an 
inverted optical microscope with a switchable brightfield / darkfield objective lens.  
Figure 5.7 shows a comparison 40 nm nanoflowers with and without aptamer 
targeting after 2 hours incubation. It is observed that there is a high amount of scattering 
from within the cells, most likely from the scattering profile of gold nanoflowers and 
consistent with the positive controls. To quantify the amount of aptamer and control 
nanoflower inside the cells, dissolved cell samples were analyzed by inductive coupled 
plasma mass spectrometry.  
Next, in order to compare size dependent uptake of gold nanoflowers, 20, 40, and 
60 nm nanoflowers functionalized with either NCL aptamer sequence or a control 
sequence were incubated at 3X concentration for 2 hours at 37 °C. Figure 5.8 shows the 
uptake profile as characterized by darkfield microscopy. From the figure, it is observed 
that 40 nm nanoflowers achieved optimal uptake into MCF-7 cells and produced the 
greatest scattering signal. At time time, there has not been an in-depth characterization of 
the nanoflower’s optical scattering profile with respect to size, therefore the uptake was 
also quantified by ICP-MS. The optical micrographs reveal that while scattering and 
uptake seems to increase with size of the nanoflowers, above 60 nm, there is a 
corresponding increase in non-specific binding of the nanoflowers to the surface.  
Finally, to compare the uptake profiles of similarly sized nanoflowers with 
spherical nanoparticles, we incubated 20 nm, 40 nm, and 60 nm nanoflowers and 
nanoparticles, functionalized with the NCL aptamer strand for 2 hours at 37 °C. Figure 
5.9 shows the brightfield and scattering profiles of each cell culture. It can be observed 
that at larger sizes, the nanoparticles are also observed to scatter light, but at a lower 
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intensity then the correspondingly sized nanoflowers. In order to quantify the uptake of 
nanoparticles and nanoflowers, each sample was repeated and analyzed by ICP-MS. 
Based on this data, we can conclude that nanoflowers, especially those roughly 40 
nanometers, are effectively uptaken by MCF-7 cells when decorated with the appropriate 
aptamer strand. Thanks to its optical scattering profile, the 40 nm nanoflower is a 
significantly improved contrast agent over spherical nanoparticles and represents and 
improvement over traditional fluorescent labels in terms of photostability and ease of use.  
5.3 Conclusions 
We have demonstrated the successful synthesis of an aptamer functional 
nanoflower structure. To optimize the growth process, we used different sized starting 
gold seeds and optimized toward a minimum growth parameter which is defined by the 
condition at which optical and physical parameters characteristic of gold nanoflowers are 
first observed from the growth of DNA functionalized gold nanoparticles. We established 
that increasing the density of DNA strands onto the surface before the growth process 
does not improve stability in OPTIMEM media but post-synthesis PEGylation proved to 
be an effective strategy without impacting the properties of the nanoflowers. Finally, we 
were able to demonstrate selective uptake of aptamer functionalized nanoflowers by 
MCF-7 cells after 3 hours of incubation at 37 °C. Thanks to the high optical scattering 
profile of the nanoflower, we were able to characterize nanoflower uptake by bright and 
dark field optical microscopy. Further work is needed to understand the mechanism of 
uptake, whether the nanoflowers are attached to the surface of the cell or uptaken into the 
intracellular space, and quantify the uptake using ion-coupled plasma mass spectroscopy 
or transmission electron microscopy. Finally, preliminary data suggests that nanoflowers 
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synthesized and characterized here exhibit much faster uptake mechanisms at a 100x 
lower concentration then similarly functionalized spherical gold nanoparticles. If 
demonstrated, we expect the faster uptake at a lower concentration, targeted cell uptake, 
and easy imaging by optical microscopy will lead to an improved platform for cell type 
characterization over traditional dye and fluorescent based assays. 
5.4  Experimental Details 
All Oligonucleotides used in current study were purchased from Integrated DNA 
Technologies Inc. (Coralville, IA). 20 nm and 5 nm gold nanospheres (AuNSs) solutions 
were purchased from Ted Pella (Redding, CA) and purified using a centrifuge before use. 
Hydrogen tetrachloroaurate(III) hydrate (HAuCl4·3H2O, 99.999%; Sigma-Aldrich), 
Hydroxylamine hydrochloride (NH2OH·HCl, 99.9999%; Sigma-Aldrich), Sodium 
hydroxide (NaOH, 98%; Sigma-Aldrich), Adenosine 5′-monophosphate sodium salt 
(AMP, 99%; Sigma-Aldrich), Tris(2-carboxyethyl)phosphine hydrochloride (TCEP, 
C9H15O6P · HCl; Sigma-Aldrich), 2-Mercaptoethanol (ME, 98%; Sigma-Aldrich) and 
mPEG thiol (CH2O-(CH2CH2O)6-CH2CH2SH, Mw = 356.5; Polypure) were used without 
further purification. 
Synthesis of the gold nanoparticles mediated by DNA. The concentration of the 
purified 20 nm gold nanospheres (AuNSs) was calculated based on Beer–Lambert law 
(Extinction coefficient of 20 nm AuNS at 520nm is 9.406*108 M-1cm-1) and then adjusted 
to 0.5 nM. 300 µL of 0.5 nM 20 nm AuNS solution was first incubated with 1 µM of 
DNA (poly A30, poly C30 or poly T30) for 15 min to let DNA adsorb onto the AuNS 
surface. 15 µL of 400 mM NH2OH (adjusted to pH 5 with NaOH) was then added to the 
AuNS solution. After vortexing, 2.1 µL 1% (wt/wt) HAuCl4 was introduced to AuNS 
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mixture solution (HAuCl4 concentration in the mixture solution is 167 µM) to initiate the 
reduction reaction. A color change (depending on the sequence of the DNA used in the 
incubation step) was observed in seconds. The mixture solution was constantly vortexed 
for another 15 min until the reaction was complete. Based on the DNA sequences used 
and their shape, the synthesized gold nanoparticles were called AuNF_A30, AuNF_C30 
or AuNS_T30 respectively. 
      Cell culture and nanoparticle incubation. AuNFs were synthesized with 1 µM of 
Fluorophore (FAM) labeled poly A30 (FAM-A30) by following the procedure in section 
2. The AuNFs were purified by centrifuge before cell incubations. CHO (Chinese hamster 
ovary) and MCF-7 cells were cultured in Dulbecco's modified eagle medium (DMEM; 
Cell Media Facility, University of Illinois at Urbana-Champaign, Urbana, IL) 
supplemented with 10% fetal bovine serum (FBS), penicillin (50 U/ml), and streptomycin 
(50 µg/ml), at 37 oC in a humidified atmosphere of 5% CO2. Cells were seeded at a 
density of 1 x 10^5 cells/cm2 on a cover glass in a 6-well plate and the cells were grown 
for 24 hours before treatment with nanoparticles. After incubation with nanoparticles 
(normally 2 hours unless otherwise noted), the cells were washed with 1XPBS five times. 
The cells were then fixed using a 4% paraformaldehyde solution in 1X PBS for 20 
minutes, and washed once more with 1XPBS before imaging.  
Characterization Methods. Shape and size of gold nanoparticles as well as the 
nano-assemblies were analyzed using a JEOL 2010LaB6 transmission electron 
microscope (TEM) operated at 200 kV. Samples were prepared by putting a drop of 
nanoparticle solutions onto a carbon-coated copper TEM grid (Ted pella). Absorbance of 
the nanoparticle solutions were characterized using UV-Vis spectrophotometry (Hewlett–
142 
 
Packard 8453). Darkfield light-scattering images were acquired using a Zeiss Axiovert 
200M inverted microscope coupled with a CCD digital camera. The individual 
nanoparticle on the glass coverslip were imaged using an EC Epiplan 50X HD objective 
(NA=0.7) and the MCF-7 cells were imaged with a Plan-Neofluar 10x objective 
(NA=0.3). Prior to acquisition, the digital camera was white-balanced using Zeiss 
Axiovision software so that colors observed in the digital images represent the true color 
of the scattered light. Z-stacks of fluorescence images of the cells were acquired using 
Andor Technology Revolution System Spinning Disk Confocal Microscope at 100X 
objective (oil immersion, excitation wavelength 488 nm). The collected z-stacks of 
images were then deconvoluted and assembled into a 3D image using Autoquant X 
software and Imaris software. 
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5.6  Figures 
 
Figure 5.1 Nanoflowers via single strand design. Nanoflowers synthesized with 
polyC30-15T-Aptamer (A) and polyC30-15T-Control (C) strands and grown from 
20 nm nanoparticle seeds. Bright field optical micrographs obtained after 2 hour 
incubation with MCF-7 cell cultures (aptamer strand and control strand, B and D, 
respectively). 
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Figure 5.2 Positive controls for PEGylated nanoflowers. 40 nm gold nanoflowers, 
post-functionalized with PEG, grown from 20 nm nanoparticle seeds and 
polyC30-T15-Aptamer (Left) and polyC30-T15-Control (Right) strands are 
incubated with MCF-7 cell cultures for 24 hours. Imaged by darkfield optical 
microscopy.  
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Figure 5.3 Cellular uptake of salt stabilized nanoflowers. The nanoparticle seeds 
were incubated in 0 mM (top), 25 mM (middle), and 75 mM (bottom) NaCl 
increased over 3 hours. The left and right column represents aptamer and control 
strands, respectively. 
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Figure 5.4 Darkfield optical micrographs obtained after 2 hour incubation of 40 
nm nanoflowers synthesized from 20 nm nanoparticle seeds with 1 strand design. 
Post functionalization with thiolated PEG to reduce non-specific binding. Aptamer 
strand (Left) and Control sequence shown (Right).  
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Figure 5.5 (Left) Nanoflowers synthesized using previously reported methods, 
note the difference in size of nanoflowers. (Right) Optimized procedures to 
synthesize a large range of nanoflower sizes with excellent homogeneity, as 
confirmed by transmission electron micrographs and dynamic light scattering. 
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Figure 5.6 Size control of nanoflowers with excellent homogeneity with post-
synthesis DNA functionalization. 20 nm nanoflowers grown from 10 nm seeds 
(aptamer and control sequences, A and B, respectively). 40 nm nanoflowers grown 
from 20 nm seeds (aptamer and control sequences, C and D, respectively). 60 nm 
nanoflowers grown from 40 nm seeds (aptamer and control sequences, E and F, 
respectively). 
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Figure 5.7 Selective uptake of aptamer decorated nanoflowers by MCF-7 cell 
culture. Bright and dark field optical micrographs of (Left) 40 nm nanoflowers, 
decorated with NCL aptamer post-synthesis, incubated with MCF-7 cell culture 
after 2 hour incubation and (Right) 40 nm nanoflowers, decorated with a control 
strand, after incubation for 2 hours under identical conditions. 
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Figure 5.8 Optical micrographs analyzing size dependent uptake of aptamer and 
control sequence decorated nanoflowers. (A, D) 20 nm nanoflowers . (B, E) 40 nm 
nanoflowers. (C, F) 60 nm nanoflowers. It is observed that while targeted uptake is 
achieved, non-specific binding and uptake seems to increase with nanoflower size. 
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Figure 5.9 Optical uptake profile of similar sized, aptamer functionalized 
nanoflowers versus nanoparticles. (Left) 20, 40, and 60 nm nanoflowers. (Right) 
20, 40, and 60 nm nanoparticles.  
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Figure 5.10 Lower and upper limits of nanoflower growth. Gold nanoflowers 
grown from 5 nm seed particles using polyA-30 strand using a (A) lower and (B) 
higher amount of gold salt. (C) Transmission electron micrograph of 200 nm gold 
nanoflowers grown from 20 nm particle seeds and 71 base pair strand. (D) Optical 
image showing the same growth conditions using a polyA-30 sequence results in 
quick aggregation of the nanoparticles (left tube) versus 200 nm nanoflowers 
structures that remain stable after 3 months of storage (right tube).  
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Figure 5.11 Comparison of cell type dependent uptake of 40 nm nanoflowers post-
functionalized with a control oligo (randomized aptamer). Bright and dark field 
optical imaging shows patches of gold and yellow representing scattering signal 
from one or more gold nanoflower. (Left) Uptake profile of MCF-7 cells, with 
little to no signal observed indicating a lack of uptaken nanoflowers. (Middle) 
Uptake profile of LnCaP cells, with an observed concentrated scattering signal 
from cell “tips,” representing a higher concentration of uptaken nanoflowers. 
(Right) Uptake profile of HeLa cells. 
